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Abstract 
Pain mitigation for surgical procedures is a topic of concern for the public, 
producers, and veterinarians. The objective of this study was to determine the 
efficacy of meloxicam for pain mitigation in adult lactating dairy cattle following a 
right-side laparotomy with omentopexy. Twenty-four dairy cattle (mean age: 2.51 
+/- 0.54 years) were enrolled. Cattle were assigned blocks based on parity, days 
in milk, milk yield, and pregnancy status, and randomly allocated to groups 
Meloxicam (MEL) or placebo treated control (CON). The study had two phases; 
sham (day 0-14) and surgery (day 15-28). On day 0, cattle were prepared for 
surgery. Injectable meloxicam (MEL) or saline placebo (CON) was administered 
(dose: 0.5 mg/kg) 5 minutes before simulated surgery (restraint for 30 minutes). 
On day 15, the surgical procedure was performed. Meloxicam or saline were 
administered prior to surgery. A right flank laparotomy, brief abdominal 
exploration, and omentopexy was performed on all animals. Blood was collected 
via jugular catheter at hours 0, 2, 4, 8, 12, 24, 36, 48, 60, & 72 during both 
phases for cortisol, and at hours 0, 2, 4, 8, 12, 24, 48, 72, 96, 120, 144, & 168 for 
haptoglobin, PGE2, and fibrinogen. Mechanical nociceptive threshold (MNT) was 
measured using an algometer and collected at hours 0, 1, 4, & 8 after sham and 
hours 0, 1, 2, 4, 8, 12, 24, 36, 48, 60, & 72 after surgery. Infrared thermography 
(IRT) was taken of the incision site at hours 0, 1, 4, & 8 hours after sham and 0, 
2, 4, 8, 12, 24, 36, 48, 60, & 72 after surgery. PGE2 concentrations displayed a 
treatment by time interaction where concentrations were higher in the CON 
animals (P = 0.003). Total cortisol concentrations were significantly increased in 
vi 
 
CON 4 hours post-operatively (P=0.004). Haptoglobin was significantly increased 
in CON 72 and 96 hours post-operatively (P< 0.001). There was no difference for 
fibrinogen (P=0.43), MNT (P=0.24) or IRT (P=0.68). This study indicates using 
meloxicam significantly reduces biomarkers of inflammation and indirect 
measures of pain and suggests meloxicam is effective in mitigating post-
operative pain in adult lactating dairy cattle. 
  
vii 
 
Table of Contents 
 
Introduction ........................................................................................................... 1 
Basic Mechanism of Pain .................................................................................. 2 
What is pain? ................................................................................................. 2 
What is the function of pain?.......................................................................... 3 
What is the basic pain pathway? ................................................................... 3 
Pain management for cattle .............................................................................. 5 
What is currently available? ........................................................................... 5 
Assessment of pain in other species ................................................................. 6 
Assessment of pain in cattle .............................................................................. 8 
What are the methods? ................................................................................. 8 
Physiologic parameters ................................................................................... 11 
PGE2 ........................................................................................................... 11 
Cortisol and CBG ......................................................................................... 13 
Haptoglobin and MMP-9 .............................................................................. 16 
Fibrinogen .................................................................................................... 19 
Mean Nociceptive Threshold ........................................................................... 20 
Thermography ................................................................................................. 24 
Meloxicam ....................................................................................................... 28 
Chapter 1 Markers of Pain Mitigation in Cattle Following Soft Tissue Surgery ... 31 
Abstract ........................................................................................................... 32 
Introduction ..................................................................................................... 33 
Material and methods ...................................................................................... 37 
Animals ........................................................................................................ 37 
Phase 1: Sham Procedure ........................................................................... 39 
Phase 2: Surgical Procedure ....................................................................... 40 
Prostaglandin E2 (PGE2) ............................................................................ 42 
Cortisol and Corticosteroid Binding Globulin ............................................... 42 
Fibrinogen .................................................................................................... 43 
Haptoglobin and MMP 9 .............................................................................. 44 
Study conclusion .......................................................................................... 44 
Statistical analysis ........................................................................................... 44 
Results ............................................................................................................ 45 
PGE2 ........................................................................................................... 45 
Cortisol and Cortisol Binding Globulin ......................................................... 46 
Fibrinogen .................................................................................................... 47 
Haptoglobin and MMP 9 .............................................................................. 48 
Discussion ....................................................................................................... 49 
Surgical Model ............................................................................................. 49 
PGE2 ........................................................................................................... 50 
Cortisol ........................................................................................................ 52 
Conclusion ...................................................................................................... 57 
viii 
 
Chapter 2 Non-Invasive Assessment of Pain Mitigation in Cattle Following Soft 
Tissue Surgery .................................................................................................... 59 
Abstract ........................................................................................................... 60 
Introduction ..................................................................................................... 61 
Material and methods ...................................................................................... 65 
Animals ........................................................................................................ 65 
Phase 1: Sham Procedure ........................................................................... 67 
Phase 2: Surgical Procedure ....................................................................... 68 
MNT ............................................................................................................. 70 
IRT ............................................................................................................... 71 
Statistical analysis ........................................................................................... 71 
Results ............................................................................................................ 72 
Mechanical Nociceptive Threshold .............................................................. 73 
Infrared Thermography ................................................................................ 73 
Discussion ....................................................................................................... 74 
Conclusions ..................................................................................................... 79 
Conclusions ........................................................................................................ 80 
Appendix ........................................................................................................... 102 
Vita .................................................................................................................... 126 
 
  
ix 
 
List of Tables 
 
Table 1 - Maximum, Mean and Minimum skin surface temperature within 72 
hours of elective right flank laparotomy with prophylactic omentopexy ...... 125 
 
 
 
 
 
 
 
 
x 
 
List of Figures 
 
Figure 1 - – Sham PGE2 concentrations by treatment group . ......................... 103 
Figure 2 - Sham PGE2 concentrations over time in all cattle. ........................... 103 
Figure 3 - Surgical PGE2 concentrations in meloxicam and placebo-treated 
cattle….…………………………………………..………………………………104 
Figure 4 - Sham total cortisol over time for all cattle ......................................... 105 
Figure 5 - Sham CBG concentration over time for all cattle .............................. 105 
Figure 6 - Surgical cortisol concentration in meloxicam and placebo treated cattle
 ................................................................................................................... 106 
Figure 7 - Surgical Cortisol Binding Globulin concentration in all cattle over time 
 ………………………………………………………………………………….107 
Figure 8 - Surgical Cortisol Binding Globulin (CBG) in meloxicam and placebo 
treated cattle  ............................................................................................. 108 
Figure 9 - Free cortisol index (FCI) for all cattle following elective laparotomy . 109 
Figure 10 - Free Cortisol Index in meloxicam and placebo-treated cattle over time
 ................................................................................................................... 110 
Figure 11 - Sham Fibrinogen concentration in all cattle over time .................... 111 
Figure 12 - Surgical Fibrinogen concentration in all cattle over time ................. 111 
Figure 13 - Surgical Fibrinogen concentrations in meloxicam and placebo-treated 
cattle .......................................................................................................... 112 
Figure 14 - Sham Haptoglobin concentrations over time for all cattle ............... 113 
Figure 15 - Sham Haptoglobin and Matrix Metalloproteinase 9 complex 
concentration in all cattle over time ............................................................ 113 
Figure 16 - Surgical Haptoglobin concentration in meloxicam and placebo-treated 
cattle  ......................................................................................................... 114 
Figure 17 - Surgical Haptoglobin and Matrix Metalloproteinase 9 complex 
concentration in meloxicam and placebo-treated cattle  ............................ 115 
Figure 18 - Surgical Matrix Metalloproteinase concentration in all cattle over time
 ................................................................................................................... 116 
Figure 19 - FD/S-3 conical steel tip used for MNT  ........................................... 116 
Figure 20 - Example of algometry sites around the incision. Sites 1, 2, and 3 are 
cranial sites and 4, 5, and 6 are caudal sites  ............................................ 117 
Figure 21 - Mechanical nociceptive threshold following a right flank laparotomy 
and prophylactic omentopexy (including times 0 and 1 hour) .................... 118 
Figure 22 - Mechanical nociceptive threshold following a right flank laparotomy 
and prophylactic omentopexy in cattle treated with meloxicam or placebo 
(excluding times 0 and 1 hour)................................................................... 119 
Figure 23 - Combined mean MNT for all cranial and caudal test sites for all cattle 
 ................................................................................................................... 120 
Figure 24 - Maximum, Mean, and Minimum skin surface temperatures collected 
by infrared thermography on all animals over time .................................... 121 
xi 
 
Figure 25 - Maximum skin surface temperatures collected by infrared 
thermography following a right flank laparotomy and prophylactic 
omentopexy in cattle treated with meloxicam or placebo ........................... 122 
Figure 26 - Mean skin surface temperatures collected by infrared thermography 
following a right flank laparotomy and prophylactic omentopexy in cattle 
treated with meloxicam or placebo ............................................................ 123 
Figure 27 - Minimum skin surface temperatures collected by infrared 
thermography following a right flank laparotomy and prophylactic 
omentopexy in cattle treated with meloxicam or placebo ........................... 124 
 
 
  
 
 
 
 
 
1 
 
Introduction 
 
 Whether for a simple headache or a highly invasive surgery, most humans 
would need and demand the use of pain medications to alleviate pain and return 
to a comfortable state. This has also become the expectation for our beloved 
house pets: dogs, cats, bird, etc. But only recently has the need for approved 
analgesia for food and fiber animals become a concern, receiving attention from 
not only veterinarians and producers but by the general public as well. Many 
surveys have been conducted asking consumers about their perceptions of food 
and fiber animals’ well-being. In a survey to the general public about their 
perspective on the ideal pig farm, respondents cited humane treatment as an 
important aspect to include (Sato et al., 2017). In a survey polling Australians, 
respondents from the general public had a better perception of castrations and 
disbudding when some form of pain management was given (Phillips et al., 
2009). Routine husbandry practices such as castration and dehorning have been 
a part of normal production for many years, but are now perceived as painful 
procedures worthy of pain mitigation by the public, producers and veterinarians. 
An approved, economical, pain management modality is needed now and is both 
desired and demanded by all aspects of the industry in animal agriculture.  
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Basic Mechanism of Pain 
What is pain? 
Pain is be defined as an unpleasant sensory experience, resulting from a 
noxious stimuli, arising from tissue damage caused by disease, inflammation or 
acute injury. Specialized sensory neurons within tissues are excited by their 
respective stimuli, which activate the pain pathway and the ultimate perception of 
the painful process (Millman, 2013). The International Association for the Study 
of Pain defines pain as “an aversive sensory experience caused by actual or 
potential injury that elicits progressive motor and vegetative reactions, results in 
learned avoidance behaviors, and may modify species specific behavior, 
including social behavior.”   
Pain can further be categorized into distinctive types: physiologic and 
pathologic. Physiologic pain is characterized by pain caused by a noxious stimuli 
causing tissue damage. This type of pain serves as a warning signal and is part 
of the body’s defense mechanism to prevent tissue damage. It is well localized, 
rapidly transmitted, and only exists for a brief time. The second type of pain is 
pathologic pain. Pathologic pain is the pain that occurs after the tissue damage 
has occurred. It is can be experienced in a number of different ways including 
causalgia (a dull, burning sensation), hyperalgesia (exaggeration of sensation to 
a noxious stimuli), and allodynia (exaggeration of a sensation that normally does 
not cause pain). Tissue damage followed by inflammation and nerve damage is 
accompanied by persistent pain, or pain that exists even after the noxious stimuli 
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has been removed. Pathologic pain is further divided into acute and chronic pain 
based on duration of the sensation. Acute pain is associated with withdrawal 
reflexes and protection of the affected areas. Typically, this type of pain is 
associated with soft tissue injury and inflammation. An example of acute pain is 
the pain present after an injury that creates a behavioral modification that 
prevents overexertion and incidentally, re-injury. Chronic pain is when the 
expected pain persists for longer than anticipated. Cancer pain, osteoarthritic 
pain and phantom limb pain are all considered chronic pain events (Lamont et 
al., 2000).  
What is the function of pain? 
 Millman et al. (2013) states that pain's functions are to “warn the animal of 
actual damage to its tissues, predict when tissue damage is likely to occur, to 
warn conspecifics of the presence of danger.” (Millman, 2013). The first function 
is most closely associated with physiologic pain, while the later describe changes 
in behavior and are more appropriate descriptions of pathologic pain. Pain leads 
to physiologic and behavioral responses such as fight, flight or freezing.  
What is the basic pain pathway? 
Nociception is the term used to refer to the physiologic components of the 
pain pathway (Anderson & Muir, 2005a). The pain pathway consists of five 
distinct steps which occur within various areas of the peripheral and central 
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nervous system: Transduction, Transmission, Modulation, Projection and 
Perception.  
 Transduction is the conversion of a noxious stimuli (thermal, mechanical, 
or chemical) into an action potential by nerve fibers present at the source, called 
nociceptors. Nociceptors are classified into two groups: A-fibers and C-fibers. 
When A-fibers are activated, the signal transmitted is associated with a sharp 
pricking sensation. This is referred to as the “first pain”. When C-fibers are 
activated, the resulting sensation is a diffuse, dull, burning sensation and is 
referred to as the “second” or “slow pain” (Lamont et al., 2000; Anderson & Muir, 
2005b). 
These action potentials originate in the nociceptors and are then 
transmitted to the central nervous system (CNS) by their corresponding afferent 
nerve fibers. A-delta nerves are myelinated, larger fibers that rapidly conduct 
action potentials. C nerves are smaller and unmyelinated and conduct signals 
much slower than A-delta (Lamont et al., 2000).  
 Action potentials reach the CNS via their respective fibers and are 
modulated at the level of the spinal cord. Modulation of an action potential is 
facilitated by descending inhibitory neurons, which occurs in the dorsal horn of 
the spinal cord. These neurons amplify or depress the signal based on several 
external variables including pharmaceutical effect. Once modulated, action 
potentials are projected to the brain where they are perceived as pain (Anderson 
& Muir, 2005b).  
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Pain management for cattle 
What is currently available? 
 United States Department of Health and Human Services Guidance for 
Industry (GFI) #123 states that for label claims of pain alleviation, the FDA 
“recommends that this indication be based on the control of clinical signs of pain 
associated with a disease.” This GFI further states “We encourage the use of 
validated methods of pain assessment in the target species.” Although guidelines 
are in place, limited validated methods for pain assessment in cattle exist, 
making new drug labeling increasingly difficult (FDA, 2006).  
 One product has been introduced to the market with a label specifically for 
pain. Transdermal flunixin meglumine (Banamine Transdermal by Merck) is the 
first drug ever for cattle to have a label indication for pain and was released in 
2017. The label specifies that this product is indicated for the treatment of pain 
associated with foot rot, but is not indicated for use in cattle over 20 months of 
age. Despite this important advance, there still is no approved products for post-
operative pain in adult lactating dairy cattle. Moreover, due to the narrow 
indications for its approval the use of Banamine Transdermal for other etiologies 
of pain is considered extra-label use.  
 Because cattle are food animals, restrictive guidelines exist to prevent 
violative residues of medications and their metabolites from entering the food 
supply. The Animal Medicinal Drug Use Clarification Act (AMDUCA) of 1994 was 
created to provide veterinarians the opportunity to determine appropriate extra-
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label uses of pharmaceuticals for veterinary species, based on their clinical 
judgment. One stipulation of extra-label drug use in food and fiber species is the 
lack of allowable tolerance or zero tolerance of detectable residues in meat or 
milk. This means when veterinarians use drugs in an extra-label manner, any 
detection of that drug or its metabolites constitutes a violation (AMDUCA, 1994).  
Assessment of pain in other species 
 Pain assessment indicators should be specific, repeatable and sensitive. 
This means that an indicator should be measuring pain and no other conditions 
(specific), repeatable within and between observers, and able to detect pain even 
when in low amounts (sensitive). Assessing the accuracy and precision of pain 
indicators, like other diagnostic tests, should be conducted by comparing them to 
a gold standard. However, there is not a gold standard for comparison when 
assessing pain in animals. Therefore, many experimental studies derive efficacy 
of pain management though comparison to animals receiving pain medication to 
those that not, or who have received varying dosages of pain medication (Ison et 
al., 2016).  
Pain in other species of animals has been validated and study extensively. 
Human medicine has identified multiple indicators of pain. Human pain 
researchers have the advantage of patients that self-report pain. For non-verbal 
patients such as infants, the elderly, or patients with language barriers, other 
mechanisms including facial grimace scales such as the Wong/Baker faces 
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rating scale can be used. Other non-verbal cues of pain in humans include 
changes in vital signs, vocalization, and muscle tension (Fink, 2000).  
 There is some controversy over whether animals experience pain in the 
same way as humans. Animals and humans share similar anatomical pathways 
as well as similar CNS responses evoked by pain. This suggests the basis for 
comparative pain perception and physiology.  
 In mice, a validated grimace scale, has been developed that takes into 
account orbital tightening, nose bulge, cheek bulge, ear position, and whisker 
changes as collective indicators of pain (Langford et al., 2010). Similar scales 
have also been developed in rabbits (Keating, Thomas, Flecknell, & Leach, 
2012), sheep (Hager et al., 2017) and horses (Dalla Costa et al., 2014). 
In pigs, consistent behavioral changes were seen following castration, tail 
docking, and needle teeth clipping including trembling, tail wagging, and head 
shaking, respectively. Removal or reduction of these behaviors upon treatment 
also suggests validity in the assessment of painful conditions, such as the 
reduction of escape behaviors seen in piglets following administration of a local 
anesthetic prior to castration. Attempts to quantify the pain threshold in pigs have 
been developed through the use of nociceptive threshold testing, either by 
thermal or mechanical means. In this method, a noxious stimulus is applied and 
the force or length of time applied is measured as an indirect assessment of the 
animal’s tolerance of the stimulus. Physiologic markers such as Fos-positive 
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neurons, cortisol, substance P, and prostaglandin E2 have also been evaluated 
as objective measures of pain in multiple species (Ison et al., 2016).  
Several issues sited in studies of pain are the unwillingness of the animal 
to show pain because an observer is present or because of sampling methods. 
Many of the domesticated food animals are prey species and have the inherent 
need to hide pain for their survival.  
Assessment of pain in cattle 
What are the methods? 
Ontologically cattle are a prey species that often hide pain in order to 
avoid predation. An example of this is the feedlot steer with respiratory disease 
that clearly elicits clinical illness when the observer is out of sight, but may 
override these signs so successfully as to be unrecognized as ill when the 
observer is present. Likewise, pain can be masked when fear overrides its 
physiologic manifestation. Cattle fear responses to humans are also influenced 
by breed and management conditions the animal has experienced. These 
responses therefore can be attenuated through positive interactions with human 
caregivers, typically from a young age, or conditioning through highly repetitive 
exposures. For example, a hand raised dairy calf is less likely to exhibit a fear 
response to a novel human than a calf that has never seen a human.  
To compound the issue, signs of pain in cattle are subject to interpretation 
by each observer. Subjective measures of pain and cattle wellness vary by 
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observer training, experience, age and gender (Coetzee, 2013). When signs of 
pain are overt and point to a specific limb or body area the assessment becomes 
more reliable, but assessment of generalized pain can be difficult (Le Bars et al., 
2001). The most common types of pain assessment in veterinary medicine are 
visual assessments where observers attempt to discern behavioral changes in 
attitude, posture, or disposition. These subjective assessments can be improved 
with the addition of categorization and appraisal of focal points such orbital 
tightening, head and neck position, and ear position. Locomotion scoring 
provides a good example where the scale for severity is divided into 4 - 5 
categories and focal points of interest are back arch, stride length, and head 
position (Grégoire et al., 2013; Groenevelt et al., 2014).  
To directly measure pain would be to directly measure the physiologic 
changes of the pain pathway. For example, measuring the frequency and 
amplitude of action potentials leaving the area of the noxious stimuli as well as its 
influence on structures within the central nervous system. Nerve conduction 
studies and electroencephalograms can provide some approximation of this data, 
but their impracticality limit implementation on a wider scale. Moreover, these 
methods do not capture the impact of pain on the affective state and therefore 
assessment of pain in cattle can truly only be measured indirectly.  
Objective measures of pain are quantifiable and are not biased by the 
observer. These methodologies produce discrete observations within animals 
overtime with response variables that can be compared across treatment groups. 
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Objective measures of pain include frequency monitoring of specific behaviors, 
blood biomarkers, pressure algometry, infrared thermography, heart rate 
monitors and remote activity monitors such as accelerometers or real-time 
location systems. Each of these methods have been used extensively in 
monitoring cattle wellness and stress.  
Subjective measures are those assessed by proxy and vary based on 
observer experience and knowledge. These are often in the form of scales, such 
as the locomotion scoring system or grimace scales. Objective measures are 
those that are not biased by the observer. These include measures such as 
blood metabolites and heart rate. Some indicators are somewhere in the middle. 
An example would be in the case of mean nociceptive threshold (MNT). This 
measures the force excreted to cause a pain reaction. Although the output is an 
objective measure, the ability of the observer to recognize the painful reaction 
would be subjective, making the overall observation open to possible bias due to 
knowledge and experience.  
Numerous indirect methods have been used to measure pain in cattle 
associated with lameness, metritis, castration, and dehorning. Methods have 
been both subjective and objective measures of inflammatory mediators and 
stress hormones, physiologic parameters, production data, and behavioral data. 
Inflammatory mediators include cortisol, haptoglobin, fibrinogen, substance P, 
and serum amyloid A. Physiologic parameters include rectal temperature and 
heart rate variation. Production data includes feed intake, average daily gain, 
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morbidity and mortality, dry matter intake and milk yield. Finally behavioral data 
includes lying time, step lengths, feed bunk aggression/displacement, and chute 
exit velocity (J. F. Coetzee, 2013a).  
Physiologic parameters 
PGE2 
Prostaglandin E2 is a positive acute phase protein and is one of the most 
important mediator for inflammatory pain (Kawabata, 2011). Prostaglandins are 
produced through the arachidonic acid pathway through cyclooxygenase (COX). 
Cyclooxygenase 1 is found across the mammalian body in peripheral tissues and 
the central nervous system. COX-1 is important for renal and gastrointestinal 
homeostasis, and its expression is increased by inflammation and pain. 
Cyclooxygenase 2 is also found in the central nervous system and is present in 
the cell in low numbers until the proper stimulus is provided (factors released by 
dying or damaged cells) (Coetzee, 2011). Cyclooxygenase 1 and 2 convert 
arachidonic acid to prostaglandin G2 which is converted further to prostaglandin 
H2 by a peroxidase. This prostaglandin H2 is converted to a number of different 
prostaglandins including PGE2, PGI2, TXA2, PGD2, and PGF2a 
(Chandrasekharan & Simmons, 2004).  
Prostaglandin E2 has an effect on the central nervous system, vascular 
smooth muscle, platelets and kidneys, and is generated from PGH2 by 3 
separate isomerases: cytosolic PGE synthase, microsomal PGE synthase-2, and 
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microsomal PGE synthase-1. Both cPGES and mPGES-2 are widely expressed 
and are important for renal homeostasis and gastrointestinal protection. The 
mPGES-1 is upregulated with COX-2 in response to an inflammatory mediators 
leading to the production of PGE2 that creates the inflammation (Kawabata, 
2011). COX-1 is responsible for the initial release of prostaglandins and is 
followed in 2-8 hours by the COX-2 mediated release. Prostaglandins cause the 
neurons’ threshold to lower, allowing for an increase in nociceptive activation. 
PGE2 is responsible in part for the central hyperalgesia that is seen with 
increased dorsal root excitability (Coetzee, 2011).  
Most research on PGE2 is focused on the reduction of this molecule in 
tissue through the inhibition of the cyclooxygenase pathway. Non-steroidal anti-
inflammatory drugs are used to decrease the inflammatory process by stopping 
the production of prostaglandins and other pro-inflammatory molecules by 
inhibiting the cyclooxygenases. NSAIDS will be discussed in further detail at the 
end of this review.  
Novel ways of inhibiting the production of PGE2 without the side effects of 
NSAIDS are being explored. These possible avenues involve blocking other 
areas in the cyclooxygenase pathway such as inhibiting mPGES-2 or selectively 
binding PGE2 receptors antagonist. A study in guinea pigs showed that by 
selectively inhibiting mPGES-1, PGE2 production is decreased apart from the 
other prostaglandins involved in this pathway (Xu et al., 2008). More specifically, 
a human study concluded that PGE2 is involved in the mediation of visceral pain 
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by inhibiting the receptors specific to PGE2 and mitigating the pain felt by 
subjects (Sarkar et al., 2003).  
Prostaglandin E2 can be measured from serum or urine. Because the 
PGE2 molecule is not stable, commercial assays are available to measure the 
metabolites and form an estimation of the PGE2 level.  
Cortisol and CBG 
Cortisol is used as a marker of stress in both humans and animals and is 
produced via activation of the hypothalamic-pituitary- axis (HPA). This axis is 
regulated by the hypothalamus releasing corticotrophin-releasing factor (CRF) 
and vasopressin (AVP). This activates the release of adrenocorticotrophic 
hormone (ACTH) from the pituitary. ACTH acts on the adrenal glands, 
specifically the zona fasciculata of the adrenal cortex, to release glucocorticoids 
such as cortisol. Glucocorticoids then act as negative feedback on the secretion 
of CRF and AVP from the hypothalamus as well as directly on the pituitary 
corticotropes to inhibit the secretion of ACTH (Pariante & Lightman, 2008). 
The HPA axis is activated in response to physical and psychological 
stressors. Cortisol’s role in the body focuses primarily on regulating metabolism 
of the cells and reducing inflammation (Ison et al., 2016). Excessive, sustained 
amounts of cortisol in the blood is referred to as hypercortisolism, and is 
commonly known as Cushing’s disease. An insufficient level of cortisol in the 
body is known as hypocortisolism, and is commonly known as Addison’s or 
Nelson’s disease.  
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Cortisol levels are affected by the intensity, duration and site of the noxious 
stimuli, and are not a measure of pain directly, but is an evaluation of the body’s 
response to distress. Activation of the HPA is prompted by a variety of physical, 
emotional and physiological challenges including surgical procedures, anxiety, 
unusual handling, extreme temperature changes, vigorous exercise and many 
other stimuli (Mellor et al., 2000). Other stressors affecting the plasma cortisol 
levels in dairy cattle include age, diet, milk yield, and environmental factors 
(Dunlap et al., 1981). Cortisol may have a maximum level it can reach in the 
body. In a study by Coetzee et al. 2008, simulated castration and surgical 
castration had similar plasma cortisol levels, which suggest that handling alone 
can reach the maximum threshold for cortisol levels. Since cortisol can rise from 
the handling alone, sample collection could cause an increase and lead to 
confounding results. To further complicate cortisol evaluation, endogenous 
cortisol secretion has a diurnal rhythm of secretion and is variable between 
individuals (Coetzee et al., 2008). After administration of exogenous cortisol, beef 
cattle’s clearance rate of the cortisol was approximately 30 minutes (Dunlap et 
al., 1981). 
Cortisol levels are also affected by the use of local anesthetics. In a study 
evaluating cortisol and dehorning, calves dehorned with the use of a local 
anesthetic had a slight rise in cortisol as a result of handling and had a second, 
large rise in cortisol after the local anesthetic wore off (Mellor et al., 2000). 
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Corticosteroid-binding globulin (CBG) is the major binding protein in the blood 
for cortisol and is produced by the liver. CBG has a high affinity for cortisol and 
binds 75% of total cortisol. Free cortisol makes up 10% of total cortisol levels, 
with another 15% bound to albumin. CBG can bind up to approximately 25 µg/dL 
of cortisol in the plasma. Once this level of binding is reached, the free cortisol 
level increases rapidly to exceed the usual 10%. This unbound portion of cortisol 
is the active cortisol that is regulated through the HPA axis. In humans, CBG is 
increased during pregnancy, hyperthyroidism, diabetes and some genetic 
disease and is decreased in hypothyroidism and protein deficiencies seen with 
severe liver disease (Carroll et al., 2011).  
In the face of inflammation, CBG has been defined as a negative APP, 
meaning it decreases in response to inflammation. This decreases the bound 
cortisol carrying capacity in the blood and would increase the amount of free 
cortisol. Because free cortisol has a short half-life, the total cortisol level may not 
change or are underestimated if CBG is decreased (Trevisi et al., 2013).  
Free Cortisol Index (FCI) is the total cortisol to CBG ratio. This has been used 
as a correlate of serum free cortisol. In a human study following healthy adults 
through major elective surgeries, FCI increased by 130% while total cortisol rose 
55% and CBG fell 30%. This measure takes into account CBG’s role in cortisol 
levels and its effect on cortisol measurement and interpretation (le Roux et al., 
2003).  
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Haptoglobin and MMP-9 
Haptoglobin (Hp) is a major positive acute phase protein (APP) in cattle 
produced by the liver and is one of the most specific APPs for inflammation and 
infection. In healthy adults, Hp is present at less than 0.1 g/L. In acutely ill adults, 
Hp levels increase over 100-fold and reach maximum levels between 48 and 96 
hours (Bannikov et al., 2011). Bovine Hp is made of an alpha and beta chain 
linked by a disulfide bond (Ceciliani et al., 2012) Hp increases during the acute 
phase of both infectious and inflammatory conditions such as those following 
surgical trauma (Chan et al., 2004). Hp also increased in times of stress due to 
increased levels of circulating cortisol (Guzelbektes et al., 2010). It has also been 
used to distinguish between chronic and acute inflammation due to the 
significantly higher levels in the acute phase of inflammation (Paulina & Tadeusz, 
2011).  
A major function of Hp is to scavenge hemoglobin released by damaged 
red blood cells. Once bound, the two proteins form a stable complex that is taken 
up by macrophages for breakdown (Alayash, 2011). This allows haptoglobin to 
act as an anti-oxidant against the oxidative damage that hemoglobin can cause. 
Hp is also responsible for some regulation of the innate immune response of 
white blood cells and has bacteriostatic effects (Ceciliani et al., 2012). It is 
essentially an anti-inflammatory during this process. Macrophages upregulated 
anti-inflammatory mediators in response to hemoglobin-haptoglobin complexes 
binding to CD163 receptors. The anti-inflammatory mediators released include 
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IL10 and heme oxygenase-1 which activate the anti-inflammatory response 
further. Haptoglobin also downregulate neutrophil activity directly by inhibiting 
lipoxygenase and cyclooxygenase or by inhibiting the respiratory burst. Hp 
further inhibits the Th2 cytokine release to suppress T cell proliferation. Finally, 
bacteriostatic activity of Hp is achieved when bacteria that need iron to grow are 
inhibited by Hp due to its scavenging of free hemoglobin. Bacteria can overcome 
the binding to utilize the heme if they are have an iron acquisition system 
(Ceciliani et al., 2012).  
In cattle, haptoglobin is used for the diagnosis and prognosis of several 
diseases including mastitis, enteritis, peritonitis, pneumonia, and metritis. The 
reproductive tracts of cattle also have Hp expression that some have 
hypothesized are part of the normal physiology of the tract. Hp also increases in 
response to disease of the reproductive tract. Dairy cattle with increased 
metabolic stress (measured through beta-hydroxybutyric acid) at the time of 
calving were found to have increase Hp. Cows with retained fetal membranes 
and those multiparous cows with assisted calving also had increases in 
haptoglobin levels  (Pohl et al., 2015).  
Hp is expressed in high rates in the liver but is also seen in the abomasum 
and forestomaches. Because the forestomach is continuously exposed to 
microbes, this explains the need for Hp as a part of the immune system dealing 
with possible breaches in the epithelium (Dilda et al., 2012).  
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In cattle, increased expression of Hp is seen with LPS infusion into the 
mammary gland as well as E. coli infections. Haptoglobin has been used as an 
indicator of disease in cattle for many years. A study measuring haptoglobin in 
milk verses serum found that animals administered LPS directly into the 
mammary gland showed an increase in Hp both in the blood and in the milk (Hiss 
et al., 2004).  
In the future, Hp may be a useful tool in slaughterhouses to assist with the 
meat inspection process. In a study comparing Hp levels of dairy cows with 
infection and metabolic disease, Hp levels were 6-fold higher than in animals with 
minor lesions. In a separate study, Hp was 40-fold higher dairy cows with acute 
lesions than healthy animals (Eckersall & Bell, 2010).  
Matrix Metalloproteinase 9 (MMP 9) is a zinc dependent proteinase in the 
gelatinase B group. They are stored in neutrophils and released during 
degranulation. They are able to breakdown the extracellular matrix and 
components of the basement membrane which increases white blood cell 
migration during inflammation. MMP 9 is also capable of activating IL-8 creating 
a positive feedback loop for more neutrophil recruitment. The Hp-MMP 9 
complex forms in the neutrophil and are stored here until degranulation. The 
release of this complex represents neutrophil activation. Measuring the Hp-MMP 
9 complex allows to differentiation of acute and chronic inflammation since it is 
only released by activated neutrophils in response to acute inflammation 
(Hanthorn et al., 2010). A study compared ELISAs for free Hp, free MMP 9 and 
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Hp-MMP 9 complexes in acute infection, chronic infection and healthy cattle.  
The results showed Hp-MMP 9 was not detectable in healthy animals and was 
the highest in animals with acute inflammation (Bannikov et al., 2011).  
Fibrinogen  
Fibrinogen is a moderate positive APP in cattle and found in healthy 
animals between 1.58-2.94 g/L (Ceciliani et al., 2012). The liver is the major 
organ for Fb production, where liver parenchymal cells produce and store Fb until 
it is needed. The major role of Fb in the body is as a precursor for fibrin formation 
and a molecule in the coagulation cascade. Fb levels following tissue damage 
increase within 24 hours and decreases once its maximum concentration is met. 
In cases of disease causing Fb to be increased, levels remain high until the 
disease has subsided (McSherry et al., 1970).  
In a study by McSherry 1970, 9 cows presented with displaced abomasa 
(DA). Three of these had fibrinogen levels greater than the reference range 
(range: 9.0-10.25 g/L). The six remaining cows were within the reference range 
(3.1-8.0 g/L) (McSherry et al., 1970). This was also seen in several other studies 
looking at fibrinogen in response to naturally occurring DAs. In a study by Jawor, 
seven cows that presented with a DA had fibrinogen levels within the 
physiologically normal range with only one elevated. This animal also had 
bronchitis as a concurrent disease (Jawor et al., 2009).  
 In a study of naturally occurring abdominal disorders (LDA, RDA and 
dystocia), Fb levels were within the reference range (3.0-7.0 g/L) prior to surgery. 
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Furthermore, surgical intervention did not elevate the levels of Fb on a systemic 
level. This study also evaluated naturally occurring traumatic reticulo-peritonitis. 
These animals had a significantly higher concentration of Fb than all other 
groups (mean: 11.6 g/L) which increase slightly following surgery and then 
lowered over time. These authors further suggest that fibrinogen is more specific 
to infectious causes of disease and that an increase after surgery would be more 
indicative for peritonitis associated with surgery (Hirvonen & Pyorala, 1998). 
Mean Nociceptive Threshold 
Mean Nociceptive Threshold (MNT) is measured by the application of a 
continuously increasing stimuli applied to tissues that reaches a pain tolerance 
threshold and causes a withdrawal or avoidance response. This threshold 
represents the maximum pressure (or pain) the subject is willing to suffer before 
a response is occurs.  Several stimuli have been used including electrical, 
thermal, chemical and mechanical. These stimuli are applied to the tissues and 
produces a quantifiable outcome that is repeatable and is non-invasive.  
Electrical stimulation meets the criteria for repeatability, quantification and 
non-invasiveness. However, this type of stimulus stimulates not only nociceptive 
fibers but also large diameter fibers used for hot and cold sensation. This 
stimulus is not typically found in the animal’s natural environment and 
effectiveness of the test may vary due to difference in impedance of different 
tissues. Thermal stimulation also meets the criteria needed for an MNT method. 
This type of stimulation does cause the activation of thermoreceptors as well as 
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nociceptors. One of the disadvantages see with this type of stimulation is the 
difference seen over black or darker areas of skin. This was demonstrated in a 
study of guinea pigs where black animals had a nociceptive threshold 8% lower 
than white animals when radiant heat was used. For chemical stimulation, an 
algogenic agent is administered and causes a slow stimulus over a longer period 
of time than the other stimuli listed. This type of stimulus is unique from others 
because the measured outcome is a measure of behavioral changes in response 
to an inescapable stimulus (Pongratz & Licka, 2017). 
The final type of nociception stimulus, and the focus of this section, is 
mechanical stimulation. An algometer is used to quantify the threshold based on 
a force exerted on the tissue. This method’s use in damaged tissues is based on 
the association of inflammation from tissue damage causing hyperalgesia or 
allodynia.  (Di Giminiani et al., 2016). This type of stimulus will also activate 
mechanoreceptors in the tissues as well as nociceptors (Pongratz & Licka, 
2017).  
The mechanical stimuli are applied until a response is obtained. Examples 
of responses to stimuli in mice and rates include tail flicking or paw withdrawals. 
In cattle, the responses measured include withdrawing the head after dehorning 
(Heinrich et al., 2010), moving away from the device, looking back at the device, 
tail flicks, and kicking.  
 Several principles have been demonstrated when using an algometer as 
a measure of pain. Tissues that are damaged whether from disease or surgical 
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trauma will have a lower threshold than those tissues that are healthy. Smaller 
algometry tips result in a lower MNT while larger tips result in a higher MNT 
(Pongratz & Licka, 2017). A certain level of variability is always present and is 
multifactorial.  
In a study of pain in dogs undergoing ovariohysterectomy and 
ovariectomy, algometry was used to measure cutaneous pain of the incision site. 
During this study a response was classified as a sudden movement away from 
the algometry unit, attempting to stand, looking at the algometry unit, 
vocalization, and attempting to bite. This study showed no difference in the two 
surgeries when comparing algometry reading, but the authors do state there is 
not an effective way of testing pain from within the peritoneal cavity at this time 
(Tallant et al., 2016).  
In a study of horse back pain, algometry tips were compared based on the 
diameter and how they elicited a response. This study found that tips with a 
contact area of 1 cm2 produced more similar results than larger or smaller tips. 
Furthermore, the shape of the tip was examined. Rounded (hemispheric shape) 
rips resulted in a higher pain threshold than cylindrical, flat tips. This study also 
compared measurements in the thoracic region verses the lumbar region of live 
horses. Because there is increased tissue thickness in the lumbar region, this 
area had a higher threshold than the thoracic region (Pongratz & Licka, 2017). 
In a study assessing the effects of meloxicam on dairy calves after cautery 
dehorning, calves were tested with a pressure algometer. Calves treated with 
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meloxicam were less sensitive to algometry 4 hours after dehorning when 
compared to calves without meloxicam (Control MNT = 1.62 ± 0.13 kg of force; 
Meloxicam MNT = 2.13 ± 0.15 kg of force) (Heinrich et al., 2010).  
This method has further been used as a way of objectively determining 
claw pain relation to locomotion scoring in dairy cattle. In this study, algometry 
was used to measure the pain in claws. The response to a stimulus in this study 
was withdrawal of the foot (Dyer et al., 2007).  
Algometry has several factors that make the results less reliable. 
Individual variation is one of the biggest factors affecting results for algometry. An 
individual’s sex, breed, age, body condition, and overall pain tolerance effect its 
MNT. The stage of disease or stage in the healing process affect the response to 
stimuli such as pressure readings. Algometry is also affected by the operator. In 
most studies, algometry is carried out by one operator who has been trained on 
the possible responses the subject by exhibit that require removal of the 
pressure. Algometry is limited by the need for repeated measurements. While 
triplicates are required for many statistical readings, subjects may become 
habituated to these readings over time. One of two scenarios could occur. One, 
the animal becomes habituated to the noxious stimuli, and its threshold will be 
falsely increased. Two, the animal begins giving the desired avoidance response 
earlier than originally intended in order to avoid the experience all together 
causing a false decrease in the threshold.   
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Thermography 
 “Running a fever” has long since been a telltale sign of sickness. 
Hippocrates speculated that when a patient was covered in mud, areas that dried 
faster had greater heat and were therefore diseased. Since the invention of the 
thermometer in the 17th century, body temperature has been used as an 
objective and quantitative means to measure sickness and its severity. An 
increased body temperature can tell physicians that body is fighting off infections, 
has an increase in inflammation, or is overheating due to the environment.  
Infrared thermography is being used in many fields to distinguish 
temperature differences, from law enforcement using this technology to rescue 
people to building engineers using this to detect heating leaks from a building. 
Now medical personnel are exploring the possibilities of how infrared 
thermography can help diagnose and monitor medical conditions.  
This modality is helpful in measuring the sympathetic adrenomedullary 
system. In a fight or flight response, skin temperature decreases as blood 
vessels constrict in the periphery to move more blood to the muscle and internal 
organs.  IRT is also helpful in measuring inflammation and pyrexia. The five 
cardinal signs of inflammation are heat, redness, swelling, pain, and loss of 
function. Temperature in inflammation increases due to vasodilation of the 
vessels at the area to increase blood flow which is also accompanied by 
inflammatory mediators such as cytokines, eicosanoids, and complement 
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proteins. These mediators work to activate PGE2 that then acts on the preoptic 
area in the brain to increase overall body temperature (Bradford et al., 2015). 
Thermal imaging is being used as a screening tool in animals and humans 
for a change in overall body temperature and the assessment of local 
inflammation. This method allows for assessing temperatures noninvasively and 
requires no physical contact between subjects and screeners. Thermal imaging 
was used to screen people at airports for increases in body temperature during 
the avian influenza outbreaks. It has been used experimentally for the detection 
and monitoring for foreign animal disease such as foot-and-mouth disease virus 
and bluetongue virus, monitoring wildlife for infectious diseases such as rabies, 
and decreasing the time needed for testing for tuberculosis in cattle (Rekant et 
al., 2016).  
Many studies have demonstrated the use of IRT for screening patients for 
increased body temperature [due to a febrile state]. In a study in calves 
inoculated with a high virulent type 2 Bovine Viral Diarrhea Virus (BVDV), 
infrared thermography of the eye was used to detect disease as early as 1 day 
post experimental inoculation, which was significantly different from pre-
inoculation temperatures, and coincided with the expected course of disease. 
This correlated with changes in rectal temperature. In this study, thermal images 
were taken of the side, back, hooves, ears, nose and eyes as well as samples of 
serum cortisol, haptoglobin and salivary IgA levels. Ocular infrared temperatures 
were the most reliable and consistent for detection of disease (A. L. Schaefer et 
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al., 2004). Because of this work, any disease that causes an animal to become 
febrile (bovine respiratory disease complex, metritis, peritonitis, etc.), can be 
detected and monitored earlier than by other traditional method without having a 
direct interaction with the patient.  
Thermal imaging has also been used for the detection and monitoring of 
localized inflammation in cattle such as hoof lesions or mastitis. These localized 
inflammatory processes are characterized by the dilation of blood vessels, 
hyperemia, swelling, and hyperthermia.  (Rekant et al., 2016). In a study of dairy 
cattle, IRT was compared to the California Mastitis Test (CMT) on its ability to 
detect subclinical mastitis. The udder skin surface temperature (SST) and CMT 
were positively correlated, while rectal temperature had a weak correlation to 
both (Colak et al., 2008). In a study of lameness in dairy cattle, temperature 
increases in the hoof with a lesion were observed before behavioral signs 
became evident and decreased once corrective trimming was performed to 
alleviate the lesion (Wood et al., 2015).  
Thermography’s use in detecting inflammation has become even more 
important when assessing the welfare of animals. Inflammation in the limbs of 
gaited horses caused by soring is being detected by governing official using IRT 
as an objective adjunct tool.  
One of the greatest advantages of IRT is the ability to collect individual 
data by a remote, noninvasive means. Observers are able to essentially snap a 
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picture of a location of interest and have a diagnostic picture of the animal’s 
health or a screening tool for monitoring herd health.  
Cow factors that would affect the quality of the thermal image include hair 
vs non-haired skin, color of skin, and age. Hair is an insulator, which holds heat 
to the body and out of sight from the IRT camera. For this reason, haired skin 
tends to appear cooler than non-haired skin. This remains true in the case of 
clipping for a surgical procedure. Black also absorbs heat more than lighter 
colors. In black and white colored cows, the black areas will be warmer than 
white areas. Finally, age has been shown to have a possible effect on body 
temperature of the eye in human subjects. Other areas where not studies but can 
be inferred to also affect theses as well.  
Environmental factors that can affect the quality of the thermal image 
include ambient temperature, air movement, sunlight, rain, and various other 
weather conditions. With the great variety of climate changes throughout a day 
and the small window of precision that the IRT camera has, the likelihood that the 
environment may alter outcomes is relatively high. For this reason, evaluating 
animals in controlled environmental conditions is imperative for the evaluation of 
thermal images. Further factors in the environment are the presence of moister 
and debris on the subject. These can limit the use of IRT in veterinary medicine 
and in practical implication in the field (Rekant et al., 2016).  
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Meloxicam 
Non-steroidal anti-inflammatory drugs (NSAID) are one of the options 
veterinarians have for treating pain and inflammation in cattle. NSAIDs inhibit 
cyclo-oxygenase enzymes (COX) from acting on the arachidonic acid pathway 
and producing prostaglandins as well as other inflammatory mediators, thereby 
decreasing pain and inflammation. COX is found in two isoforms: COX-1 and 
COX-2. COX 1 is primarily related to homeostats of the abomasal mucosa and 
renal perfusion and is constantly expressed in the CNS and PNS. Long term 
alteration in COX-1 expression can lead to effects of the medications such as 
ulceration of the abomasum. COX-2 is found in the CNS constantly, but is 
induced by release of factors from injured tissue. This leads to its role as a major 
enzyme in prostaglandin production. After a tissue insult, COX-2 mRNA 
expression takes 2-8 hours to reach maximum levels. For this reason, COX-1 is 
predominantly responsible for the initial release of prostaglandins (Coetzee, 
2013b).  Medications that are more selective for COX-2 are thought to be less 
potent (Anderson & Edmondson, 2013) 
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) in the 
oxicam class. Meloxicam is more selective for the COX-2 isoform. The dose 
approved by the European Union is currently 0.5 mg/kg IM or SC and has a 15-
day meat withdrawal and a 5-day milk withdrawal time.  
Meloxicam is currently approved in the USA for use in dogs and cats. In 
dogs, meloxicam is approved for use to control pain and inflammation associated 
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with osteoarthritis ("Metacam Injectable for Dogs"). In cats, meloxicam is labeled 
for control of post-operative pain and inflammation from spays, neuters, and 
orthopedic surgery. This label does have a box warning stating that repeated 
doses in cats is associated with acute renal failure and death ("Metacam 
Injectable for Cats").  
There are a number of studies evaluating meloxicam’s efficacy in cattle for 
several different indications. The American Association of Bovine Practitioners 
guidelines for castration and dehorning sites meloxicam as a possible long-acting 
pain medication to mitigate pain associated with these procedures (Practitioners, 
2014). Allen and colleagues (Allen et al., 2013) found that calves treated with 
meloxicam had significantly lower cortisol levels at 4 hours after dehorning and 
substance P levels at 120 hours than control calves regardless of time of 
meloxicam administration (either 12 hours pre-procedure or at time of 
procedure). Heinrich and colleagues (Heinrich et al., 2010) found that calves 
treated with meloxicam 10 minutes prior to dehorning flicked their ears less 
during the first 44 hours, had less head shaking during the first 9 hours, and were 
less sensitive to pressure algometry at 4 hours after the procedure than the 
control calves. Barrier and colleagues (Barrier et al., 2014) found that beef cows 
given meloxicam following caesarean section spent more time lying and had 
more lying bouts than control animals, suggesting that increased lying times are 
representative of increased comfort.  
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Coetzee and colleagues (Coetzee et al., 2009) evaluated the pharmacokinetics 
of meloxicam in ruminant calves receiving the medication either orally (1 mg/kg) 
or intravenously (0.5 mg/kg). Oral meloxicam had a mean peak plasma 
concentration of 3.10 µg/mL at 11.64 hours with a half-life of 27.54 hours. 
Intravenous administration of meloxicam had a half-life of 20.35 hours. Malreddy 
and colleagues evaluated the pharmacokinetics of meloxicam in lactating dairy 
cattle when given orally with two different dosing levels of gabapentin. Oral 
meloxicam had mean peak plasma concentration of 2.89 µg/mL at 11.33 hours. 
The mean peak milk concentration was 0.41 µg/mL at 9.33 hours (Malreddy et 
al., 2013).  
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Chapter 1 
Markers of Pain Mitigation in Cattle Following Soft Tissue 
Surgery 
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Abstract  
Mitigation of pain for surgical procedures has become a topic of concern 
for the public, producers, and veterinarians. The objective of this study was to 
determine the efficacy of meloxicam for pain mitigation in adult lactating dairy 
cattle following a right-side laparotomy with omentopexy. Twenty-four dairy cattle 
(mean age: 2.51 +/- 0.54 years), between 50 and 188 days in milk (median: 117 
days +/- 43.15 days) were enrolled. Cattle were administered a 7-day acclimation 
period to the new environment and social hierarchy and assigned blocks based 
on parity, days in milk, milk yield, and pregnancy status, and randomly allocated 
to groups Meloxicam (MEL) or placebo treated control (CON). The study had two 
phases; sham (day 0-14) and surgery (day 15-28). The objective of the sham 
phase was to collect baseline behavioral and physiologic data and permit cows to 
become acclimated to human intervention during the intensive sampling periods. 
On day 0, cattle were prepared for surgery including local blocks with lidocaine. 
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Injectable meloxicam (MEL) or saline placebo (CON) was administered (dose: 
0.5 mg/kg) 5 minutes before simulated surgery (restraint for 30 minutes) and then 
returned to their home pen for data collection. On day 15, after a 14-day washout 
period, the surgical procedure was performed. Meloxicam and saline were 
administered prior to surgery to each respective group. A right flank laparotomy, 
brief abdominal exploration, and omentopexy was performed on all animals. 
Blood was collected via jugular catheter at hours 0, 2, 4, 8, 12, 24, 36, 48, 60, & 
72 during both phases for cortisol, and at hours 0, 2, 4, 8, 12, 24, 48, 72, 96, 120, 
144, & 168 for haptoglobin, PGE2, and fibrinogen. PGE2 concentrations 
displayed a treatment by time interaction where concentrations were higher in the 
CON animals (P = 0.003). Total cortisol concentrations were significantly 
increased in CON 4 hours post-operatively (P=0.004). Haptoglobin was 
significantly increased in CON 72 and 96 hours post-operatively (P< 0.001). 
There was no difference for fibrinogen (P=0.43). This study indicates the use of 
meloxicam significantly reduces biomarkers of inflammation and indirect 
measures of pain and suggests meloxicam is effective in mitigating post-
operative pain in adult lactating dairy cattle. 
 
Introduction 
Cattle undergo painful livestock management procedures every day such 
as dehorning and castration as well as surgical repairs of displaced abomasum 
(DA), rumenotomies, and caesarian section (C-section). According to the United 
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States Department of Agriculture (USDA), there are an estimated 9.4 million 
dairy cows in the US in 2018 (Cessna, 2018). The incidence of left displaced 
abomasum (LDA) in lactating dairy cattle is approximately 5% with a projected 
cost of $250 to $450 per case (van Winden, 2002). Therefore, approximately 
470,000 cows undergo surgical correction for LDAs each year. Veterinarians 
scored abdominal surgeries, such as DA corrections and caesarian sections, as 
the most painful procedures cattle undergo with an average pain score of 7.3 and 
8.0, respectively (Fajt et al., 2011). To address pain mitigation, practitioners used 
a variety of medications including nonsteroidal anti-inflammatory drugs 
(NSAIDS), opioids, α2 adrenergic receptor agonist, local anesthetics, or a 
combination of these for pain in response to surgery. 
Although practitioners are aware of the pain induced with abdominal 
surgery and use a wide variety of medications to alleviate pain, only one 
medication is currently labeled for the mitigation of pain in cattle. The recently 
approved transdermal flunixin meglumine (Banamine® Transdermal, Merck 
Animal Health, 2017) has a label indication for pyrexia associated with bovine 
respiratory disease and control of pain associated with foot rot. However, this 
product is not currently labeled for use in dairy cattle over 20 months of age. This 
obligates practitioners to continue to use medications in an Extra Label Drug Use 
(ELDU) manner under the guidance of the Animal Medicinal Drug Use 
Clarification Act (AMDUCA). The cattle industry needs new products labelled 
specifically for post-operative pain that are safe, effective and cost efficient.  
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Meloxicam, although not approved for use in cattle in the United States, is 
widely used for pain and other indications in cattle of many ages and production 
systems. In Canada, meloxicam (Metacam®20, Boehringer Ingelheim (Canada) 
Ltd., Burlington ON) is indicated for calf diarrhea, mastitis, and the relief of pain 
associated with dehorning and abdominal surgery. Meloxicam acts by inhibiting 
cyclooxygenase enzymes from converting arachidonic acid to prostaglandins and 
prostacyclins. There are two isoforms of the COX molecule: COX-1 and COX-2. 
COX-2 is present in low levels within the cell and is upregulated in response to 
inflammation. Meloxicam preferentially inhibits COX-2 thereby decreasing the 
inflammatory mediators release and depressing the inflammatory response. 
Following a single subcutaneous dose, meloxicam displays peak plasma 
concentrations in 7.7 hours (Cmax = 2.1μg/ml) and an elimination half-life of 
approximately 22 hours in young cattle (Stock & Coetzee, 2015). Meloxicam’s 
efficacy in alleviating pain associated with castration and dehorning has been 
well documented (Allen et al., 2013; Brown et al., 2015; Heinrich, Duffield, 
Lissemore, & Millman, 2010; Melendez et al., 2017). Barrier et al. recently 
demonstrated changes in lying time and lying bouts in beef cows undergoing 
emergency caesarian section following a single subcutaneous dose of 
meloxicam. Likewise, meloxicam treated cattle displayed a higher dry matter 
intake and altered lying time after implantation of a rumen fistula compared to 
ketoprofen treated cattle (Barrier et al. (2014).  
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A major hurtle in the approval of new pain medications is the ability to 
objectively measure and quantify pain in cattle to meet FDA specifications ("GFI 
#123-Target Animal Safety-Approval of NSAIDS,"). Pain is an inherently variable 
and individual response, influenced by temperament, breed, and each animal’s 
physiologic and/or affective state. Current research methodology attempts to 
quantify pain indirectly through inflammatory or neuropeptide biomarkers, 
changes in behavior, or changes in production parameters. Cattle are 
ontologically prey species, and are behaviorally conditioned to mask pain or 
disease in order to avert predation. Therefore, the pursuit of systemic biomarkers 
that are byproducts of the pain or inflammatory response are attractive for 
evaluating the efficacy of pain therapies in clinical studies. To the authors’ 
knowledge, no previous studies have evaluated the efficacy of meloxicam in 
alleviating post-operative pain in lactating dairy cattle.   
Thus, the objective of this study was to evaluate the efficacy of 
subcutaneously administered meloxicam in alleviating post-operative pain in 
lactating dairy cattle following elective laparotomy with prophylactic omentopexy. 
Our hypothesis was that cattle administered meloxicam would demonstrate lower 
concentrations of relevant biomarkers associated with pain and inflammation 
(cortisol, CBG, PGE2, Hp, Hp – MMP9 complex, and fibrinogen) compared to 
placebo administered cattle.  
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Material and methods 
 The University of Tennessee Institutional Animal Care and Use Committee 
approved all experimental procedures under the supervision of the university 
veterinarian (Protocol # 2246-0314). 
The study was conducted in two phases. Animals were first subjected to a 
sham surgical procedure to ensure habituation to the intensive sampling 
procedures followed by application of the surgical procedure after a 14-day wash 
out period. Data are presented in relationship to each phase.  
Animals 
Twenty-four adult dairy cattle, greater than 20 months of age (mean age: 
2.51 +/- 0.54 years), were housed at the East Tennessee Research and 
Education Center - Little River Dairy Animal and Environmental Unit (Latitude: 
35.772115; Longitude: -83.850182) during the months of June, July and August 
and were maintained in an ambient temperature. Animals were between 50 and 
188 days in milk (median: 117 days +/- 43.15 days) and weighed between 512 kg 
and 705 kg (mean: 596.4 kg +/- 41.8 kg). Cows were allocated into two equal 
groups: Meloxicam (n = 12; MEL) and Control (n = 12; CON). Groups were 
balanced based on days in milk (Median: 111 days MEL; 127 days CON; Range: 
50 – 188 days), milk yield (Mean: 74.0 lbs. MEL; 77.5 lbs. CON; Range: 57.6 – 
93.1 lbs.), and pregnancy status (n = 2 MEL; n = 2 CON). Exclusion criteria for 
enrollment in the study included clinical signs associated with potentially 
systemic inflammation (i.e. mastitis, metritis, ketosis, lameness, etc.) or history or 
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evidence of previous abdominal surgery. All animals were considered healthy 
based on a physical exam performed by a veterinarian 1 day prior to the start of 
the study.  
Cattle were housed in a free stall barn approximately 20 m x 12.5 m (800 
sq. m) with 24 sand-bedded stalls and 32 headlock stanchions. Stocking density 
was maintained at 75% and did not exceed 100% during the study (lowest was 
22 cows per 24 stalls = 91%). Cattle were milked twice daily (at approximately 
7:30 AM and 4:30 PM). Milk was discarded throughout the entire of the 
experiment.  A total mixed ration (TMR) was fed ad libitum during the study and 
was formulated according to Nutrient Research Council requirements to meet or 
exceed nutrient requirements of lactating dairy cattle. Nutrient analysis of TMR 
was conducted prior to and upon completion of the study. Fresh TMR was 
prepared and dispensed twice daily in parallel with milking. Twice daily at 
approximately 12:00 PM and 6:00 PM residual TMR was pushed up the 
headlocks. Waste TMR was collected twice daily immediately prior to the 
dispensing of each new feeding and weighed to determine pen level feed intake. 
Throughout the study animals were also provided ad libitum access to water. The 
cattle were permitted 7 days prior to the initiation of the study to acclimate to the 
new environment and social hierarchy. During this time, the cattle were also 
acclimated to handling via halters and grooming to simulate the contact 
associated with the intense sampling periods.  
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Phase 1: Sham Procedure 
In order to determine the effect of the intense sampling scheme and 
experimental assessments alone without the influence of the surgical procedure, 
a sham experimental phase was imposed on the cattle. On day -1, a 14-gauge X 
13 cm polyurethane IV jugular catheter (MILACATH-Extended Use, Mila 
International, Inc. Florence, KY) was placed and were maintained with 
heparinized saline until 4 days after the procedure, at which point they were 
removed and subsequent samples taken via direct venipuncture.  
On day 0, a sham procedure was performed.  Cows were prepared for 
sham surgery by clipping and sterilely preparing. Cows were blocked with 2% 
lidocaine (90 ml or 1800 mg, local tissue infusion, VetOne, MWI Animal Health, 
Boise, ID) in a line block pattern on their right side approximately 15 cm below 
the transverse process of the 3rd lumbar vertebrae and 10 cm caudal to the 
costal arch. Meloxicam (0.5 mg/kg, Metacam®20, Boehringer Ingelheim Ltd., 
Burlington, Ontario, Canada) was administered SQ in the neck to the meloxicam 
treatment group (MEL) and saline (0.025 mL/kg, 0.9% Sodium Chloride Injection 
USP, Hospira, Inc. Lake Forest, IL) was administered SQ in the neck to the 
control group (CON). Ampicillin trihydrate (10 mg/kg, Polyflex®, Boehringer 
Ingelheim Ltd., St. Joseph, MO) was administered intramuscularly to all cows on 
the contralateral side of the neck from the treatment.  
Four veterinarians were designated as surgeons during the study (MC, 
DA, BW, and LS). Six replicates of sham procedures occurred with 4 animals per 
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cohort. Each cohort was equally balanced for MEL and CON cattle (2 MEL and 2 
CON). Each surgeon performed six procedures with equal numbers of MEL and 
CON cattle (3 MEL and 3 CON). A sham surgical simulation was performed with 
the surgeon standing adjacent to the animal while it was restrained for 30 
minutes. Procedure initiation for each cohort was staggered and administration of 
treatment and sampling time points were relative to each animal’s sham 
procedure start time.  
Following the sham procedure, cattle were returned to their home pen for 
sample collection lasting up to 7 days. Following completion of phase 1, the 
cattle were provided a 7-day washout period. Therefore, a total of 14 days 
following administration of the meloxicam or saline placebo elapsed prior to 
initiation of phase 2.    
Phase 2: Surgical Procedure 
The methods used for the phase 2 were similar to those executed during 
phase 1 with the exception of preforming right flank laparotomies with 
prophylactic omentopexy for all cattle. Briefly, on day -1 before the surgical 
procedure, cattle were refitted with heart rate monitors and jugular catheter was 
placed. As previously, jugular catheters were maintained with heparinized saline 
through the first 96 hours of the sampling period then removed and subsequent 
blood samples collected via direct venipuncture. On day 0, approximately 5 
minutes prior to the initiation of each animals’ surgical procedure, meloxicam (0.5 
mg/kg) was administered SQ in the neck to the meloxicam treatment group 
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(MEL) while a saline placebo (0.025 mL/kg) was administered SQ in the neck to 
the control group (CON). Ampicillin trihydrate (10 mg/kg) was administered 
intramuscularly to all cows on the contralateral side of the neck from the 
meloxicam or saline treatment. 
The same four veterinarians carried out the surgical procedures in 6 
replicates of 4 cows. All treatments were balanced within each cohort and 
balanced across each surgeon. Each laparotomy, abdominal exploratory and 
prophylactic omentopexy were performed according to a standardized protocol. 
The right paralumbar fossa was clipped, the skin was aseptically prepared, and a 
line block with lidocaine (120mL of lidocaine) was performed as previously 
described. After aseptic preparation, a 15 cm vertical incision was made starting 
10-cm caudal to the caudal curvature of the last rib and 15 cm ventral to the 
transverse process of the 3rd lumbar vertebrae. The incision progressed through 
the skin, external abdominal oblique muscle, internal abdominal oblique muscle, 
transversus abdominus muscle, and peritoneum. The surgeon then placed the 
left arm into the abdomen and briefly explored the abdomen to identify and 
palpate the rumen, omentum and abomasum. Similar to the techniques 
described in Turner and McIlwraith’s Techniques in Large Animal Surgery (2013), 
a standard omentopexy was performed by suturing the omentum, peritoneum 
and transversus closed using #2 polyglactin 910 (Vicryl, Ethicon, Inc. Somerville, 
NJ) in a simple continuous pattern. The external abdominal oblique muscle and 
internal abdominal oblique muscle were also closed using #2 polyglactin 910 in a 
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simple continuous pattern. Finally, the skin was closed using #4 nylon (Supramid 
Extra II. S. Jackson, Inc. Alexandra, VA) in a continuous interlocking pattern. 
Prostaglandin E2 (PGE2) 
Blood samples (5 mL) were collected into a lithium heparin tube at 0 
(baseline), 2, 4, 8, 12, 24, 48, 72, 96, 120, 144, and 168 after sham/surgery. 
Plasma was harvested after centrifugation and frozen until analyzed. A 
commercially available kit was used to measure the PGE2 metabolites 
(Prostaglandin E Metabolite (Kit # 514531), Cayman Chemical Company, Ann 
Arbor, MI) following previously described methodology (Fraccaro et al., 2013). 
Briefly, the stable metabolite of PGE2 was measured in a competitive assay with 
a PGE metabolite conjugated with acetylcholinesterase. The concentration of 
PGE metabolite tracer was determined spectrophotometerically and used to 
calculate the concentration of free PGE metabolite. Absorbances were read by 
an ELX808 (BioTek Instruments, Inc., Winooski, VT). Intra- and inter-assay CV (n 
= 570) of pooled bovine plasma was 10.7% and 4.0%, respectively. 
 
Cortisol and Corticosteroid Binding Globulin  
Blood samples (6 mL) were collected into a lithium heparin tube at 0 
(baseline), 2, 4, 8, 12, 24, 36, 48, 60, and 72 after sham or surgery. Plasma was 
harvested by centrifugation and frozen until analyzed. Isolation and purification of 
corticosteroid-binding globulin from bovine plasma (CBG) and development and 
validation of an ELISA for its quantification followed the procedures outlined by 
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Roberts et al. (2003) for porcine CBG.  For the CBG assay the absorbances 
were read by an ELX808 (BioTek Instruments, Inc., Winooski, VT) and data were 
collected using Gen5 software version 2.03.1 (BioTek Instruments, Inc., 
Winooski, VT).  Intra- and inter-assay CV of pooled bovine plasma was 5.6% and 
9.7%, respectively. Total serum cortisol concentration (ng/mL) was determined 
using the RIA procedure of Coat-A-Count Cortisol (Siemens Medical Solutions 
Diagnostics, Los Angeles, CA) as performed previously in our lab (Doherty et al., 
2007).  The free cortisol index (FCI; nmol/mg) was calculated using the ratio of 
plasma total cortisol (nmol/L) to CBG (mg/L; Le Roux et al., 2003). 
Fibrinogen 
Blood samples (6 mL) were collected into a lithium heparin tube at 0 
(baseline), 2, 4, 8, 12, 24, 48, 72, 96, 120, 144, and 168 hours after the sham 
and surgery procedures. Serum was harvested by centrifugation and frozen until 
analyzed. Fibrinogen was measured using the heat precipitation method. Two 
microhematocrit tubes were filled with plasma. The first tube was centrifuged and 
the total protein was measured using a refractometer. The second tube was 
heated to 56 C° for 3 minutes, centrifuged, and the total protein was measured. 
This precipitates the fibrinogen from the plasma. The second protein 
measurement from the heated tube was subtracted from the first protein 
measurement of the unheated tube with the difference being the fibrinogen level. 
The % CV of all samples (n = 576) was 8.1%.  
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Haptoglobin and MMP 9 
Blood samples (5 mL) were collected into a serum clot activator tube at 
baseline prior to sham/surgery and hours 2, 4, 8, 12, 24, 48, 72, 96, 120, 144, 
and 168 after sham/surgery. Blood were collected into a serum clot activator 
tube. Serum was harvested by centrifugation after clotting and frozen until 
analysis. Hp was analyzed as previously described using a commercially 
available bovine haptoglobin ELISA test kit following the manufacturer’s 
instructions (Hanthorn et al., 2014). 
Study conclusion 
A 30-day investigational withdrawal period, mandated by the food-use 
authorization, was used for edible tissues following the last treatment. In addition, 
a 10-day investigational milk discard time was used following the last treatment 
of meloxicam.  
Statistical analysis  
All statistical analyses were performed in Statistical Analyses System 
(SAS Version 9.1: SAS Institute Inc., Cary NC; 1991-2001). The level of 
significance was established to be P< 0.05. 
 Normality test of the data and residuals was performed for each indicator. 
Surgery total cortisol, fibrinogen, and PGE2 concentrations were normally 
distributed. Surgery CBC, free cortisol index, Hp-MMP 9 and Haptoglobin 
concentrations were normally distributed following log transformation. Non-
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normally distributed data was log transformed to achieve normal distribution. 
Data was analyzed using the GLIMMIX procedure of SAS with Tukey adjustment. 
Fixed effects included treatment group. Time was used as a repeated measure.  
Animal ID was used as a random effect for all blood markers. Surgeon and time 
of surgery (surgery block) was analyzed as a random effect, but did not have a 
significant effect on any blood markers and was therefore removed from the 
analysis.  
Results 
 Two animals were removed during the course of the study; one due to 
developing mastitis (CON) and one due to surgical complications (MEL), and 
have not been included in the statistical analyses. Cows included in the results is 
n = 22 (n = 11 MEL; n = 11 CON).   
Surgeries were performed in the unused free stall pen adjacent to the 
home pen. The surgery time began when the incision was started and ended 
when the last suture was tied. Surgeries ranged from 12 to 36 minutes (mean 
time was 24.41 minutes). If surgeons finished before 30 minutes, cattle were 
maintained in their surgical position until 30 minutes was completed. Time point 0 
hours represents the start of the incision for each animal.  
PGE2 
During the sham procedure, there was not a treatment by time interaction 
(P = 0.31). There was an effect of treatment (P = 0.02; Figure 1) and time (P < 
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0.001; Figure 2) on plasma concentrations of PGE2 such that CON PGE 
concentrations were greater than MEL.  
During the surgery period, there was not an effect of treatment (P = 0.11). 
However, there was an effect on time (P < 0.001) and a treatment by time 
interaction (P = 0.003; Figure 3) on plasma PGE2 concentrations, such that the 
CON group had greater concentrations at 2 and 8 hours after surgery (P= 0.004 
and P<0.001, respectively). 
Cortisol and Cortisol Binding Globulin 
During the sham phase, total cortisol concentration was affected by time 
(P = 0.016), but not significantly affected by treatment (P = 0.14), nor was there a 
time by treatment interaction (P = 0.27). However, all cows displayed a decline in 
total cortisol concentration over the observation period (P = 0.015, Figure 4). 
CBG displayed a similar pattern were there was a time effect (P < 0.001), but 
was not affected by treatment (P = 0.08) or a treatment by time interaction (P = 
0.58). However, a decline in CBG over time was observed for all cows (P > 
0.001, Figure 5). Finally, due to the comparative declines in both total cortisol 
and CBG, the FCI had no significant time (P = 0.10), treatment (P = 0.25), or time 
by treatment interaction (P = 0.17, data not shown).  
Total cortisol concentration was affected by both a time across treatment 
groups (P < 0.001) and a time by treatment interaction (P = 0.004) following the 
surgical procedure. Figure 6 displays the least squares mean concentrations of 
cortisol by treatment group over time after surgery. Cows that received 
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meloxicam had significantly lower cortisol concentrations at 4 hours after surgery 
(P < 0.001) than placebo-treated controls.  
Unlike the observations made in the sham phase, CBG concentrations 
demonstrated a significant rise over time in both treatment groups (P < 0.001, 
Figure 7), but these differences were not significant by treatment (P= 0.14) or 
time by treatment interaction (P = 0.52, Figure 8). Due to the overall rise in total 
cortisol in the early post-operative period and the slowly rising CBG 
concentration in both treatments, FCI demonstrated a significant elevation post-
operatively that declined as cortisol normalized, and CBG continued a parallel 
rise for both treatment groups (P < 0.001, Figure 9). However, despite the 
differences in early total cortisol concentrations, there was no significant 
treatment effect (P = 0.34) or time by treatment interaction (P = 0.29, Figure 10).  
Fibrinogen 
 Interestingly, fibrinogen concentrations slowly declined over the 
observation period during the sham phase (P < 0.001), despite the lack of 
induced inflammation in either group, and as expected there were no treatment 
(P = 0.52) or time by treatment interactions (P = 0.96, Figure 11). 
During the surgery phase, fibrinogen concentration displayed a rise and 
plateau between 4-hr and 144-hr post-operatively with a significant time effect (P 
< 0.001, Figure 12), however there was no treatment effect (P = 0.56, Figure 13) 
or time by treatment interaction (P = 0.43).  
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Haptoglobin and MMP 9 
 During the sham procedure, Hp concentrations exhibited a peak at 72-hr 
with an overall time effect for all cattle (P = 0.002), but no treatment (P = 0.42) or 
time by treatment interaction (P = 0.39, Figure 14). Hp-MMP 9 complex 
concentration likewise, exhibited brief spikes in concentration at 24-hr and 144 – 
168-hr during the sham procedure with an overall time effect (P < 0.001), but no 
treatment (P = 0.15) or treatment by time interaction (P = 0.36, Figure 15).  
 During the surgery procedure, Hp concentration were observed to have 
both time effects (P < 0.001) and time by treatment interaction (P < 0.001), but 
not a treatment effect (P = 0.66, Figure 16). Placebo-treated control animals had 
significantly higher Hp concentrations are 72 and 96 hours after surgery (P = 
0.015 and <0.001, respectively). 
Hp-MMP 9 complex concentration, displayed a similar pattern with a peak 
in concentration around 48-hr for both treatment groups (Figure 17) with a 
significant time effect and time by treatment interaction (P < 0.001 and P = 0.012, 
respectively), but no difference between treatments (P = 0.5317). Control cows 
had a significantly lower Hp-MMP 9 complex concentration at 72 hours post-
surgery. Hp-MMP 9 complex concentrations in all cows over time displayed a 
significant time effect (P < 0.001, Figure 18). Complex concentrations at hours 8, 
12, 24, and 48 were significantly higher in all cows following surgery. 
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Discussion 
This study supports the hypothesis that meloxicam is effective in reducing 
pain and inflammation following soft tissue surgery. The increase in PGE2, 
cortisol and haptoglobin in the control animals indicate a response to the acute 
inflammation and pain following an elective laparotomy with prophylactic 
omentopexy. Meloxicam reduced these markers at varying time points after 
surgery in treated animals.  
Surgical Model 
The surgical model chosen for this study was a standing right flank 
laparotomy with prophylactic omentopexy (simulated correction of an LDA). This 
model accurately reproduces the sharp, acute pain associated with a surgical 
procedure as well as the inflammatory pain experienced during the healing 
process. All the animals enrolled in the present study recovered without 
complication with the exception of one. This animal developed an intestinal 
entrapment associated with the omentopexy and was subsequently exclude from 
the statistical analysis on the basis of the exaggerated inflammatory response 
she was perceived to be experiencing. An additional animal developed a new 
intramammary infection during the study and was excluded as well on the basis 
of the confounding inflammatory process. Cattle enrolled in the present study can 
be characterized as early to mid-lactation (DIM: 50 – 188 days, median: 121 
days). Naturally occurring displaced abomasa often occur at higher incidence 
earlier in lactation, classically within the first 14 DIM and frequently occur as the 
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result of or along with concurrent co-morbidities such as ketosis, hypocalcemia, 
retained fetal membranes, metritis or mastitis. Likewise, cattle with disease 
processes indicating surgical intervention, such as dystocia requiring Cesarean 
delivery, may be in an altered physiologic state compared to the cattle 
represented in the present study. Whether these co-morbidities would have 
confounded the results demonstrated here is not known, but it probable that 
NSAID therapy, such as meloxicam, would provide therapeutic benefit for cattle 
experiencing these types of systemic inflammatory responses. Regardless, these 
factors should be considered when comparing the results observed here to 
clinical applications.  
PGE2 
 The reduction of prostaglandins by NSAIDs is the main method of 
analgesia and anti-inflammatory effects produced by these drugs. PGE2 is one 
product of the Arachidonic Acid pathway and is upregulated by the COX-2 
enzyme increases during inflammation. For this reason, PGE2 is expected to 
decrease when the patient is given a COX-2 inhibitor such as meloxicam. This 
has been demonstrated in several studies prior to the current one. Meloxicam 
significantly reduced PGE2 concentrations in blood and synovial fluid of dogs 
treated with meloxicam for 21 days. This is consistent with the suppression of the 
COX-2 enzyme (Jones, Streppa, Harmon, & Budsberg, 2002).. In a human study 
using whole blood and microsomal assays, meloxicam preferentially inhibited 
human COX-2 at 0.01 to 1 µmol/L but was as potent of an inhibitor of both COX-
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1 and COX-2 at higher concentrations. In the microsomal assay, meloxicam was 
again highly selective for COX-2 (Churchill et al., 1996). Finally, in a study of 
cautery dehorning in calves, meloxicam treated calves had a significantly lower 
PGE2 level than control calves (Allen et al., 2013). The present study follows 
these same principles of PGE2 reduction in response to meloxicam. The 
reduction of PGE2 was significant at 2- and 8-hours following surgery. Some 
studies even suggest that spinal PGE2 may be responsible for the increased 
excitability in the dorsal root leading to hyperalgesia (J.F. Coetzee, 2011). 
Because PGE2 is a known inflammatory mediator and cause pain, regulating the 
magnitude of this response mitigates pain. 
Inhibition of prostaglandin and prostacylin production is the primary target 
of NSAID therapy. Reduction in these products, reduces the downstream 
mediation of inflammation and pain. PGE2 is one product of the arachidonic acid 
pathway and is increased upon induction of the cyclooxygenase-2 (COX-2) 
enzyme during inflammation. For this reason, PGE2 is expected to decrease 
when the patient is given a COX-2 inhibitor such as meloxicam. In fact, multiple 
COX-1 and COX-2 inhibitors such as, acetylsalicylic acid, flunixin meglumine and 
a celecoxib have been shown to reduce PGE2 production in in vitro isolated 
bovine peripheral mononuclear cells (Myers et al., 2010). Because PGE2 is a 
well described marker of inflammatory pain, regulating the magnitude of this 
response mitigates pain. Moreover, it has been suggested in cattle that spinal 
PGE2 may play a role in increased excitability in the dorsal root of the spinal 
52 
 
cord, leading to hyperalgesia, therefore systemic administration of meloxicam 
and reduction of incipient PGE2 production may decrease the overall 
transduction and perception of pain (Coetzee, 2011).  
In the present study, meloxicam suppressed the synthesis of PGE2 at 2- 
and 8-hours following surgery. Although the plasma kinetics of meloxicam were 
not directly measured in these animals, the reduction in PGE2 concentrations 
parallel previously reported pharmacokinetics data following subcutaneous 
administration of meloxicam. Other studies have demonstrated meloxicam Cmax 
was reached between 6 – 8 hours following administration. Allen et al (2013) 
observed a decline in PGE2 concentrations in dairy calves treated with oral 
meloxicam at the time of cautery dehorning that extended out 48 hr. after the 
procedure. Likewise, cattle subjected to a tissue cage implantation model, 
demonstrated a 48 hr. reduction in PGE2 in the cage exudate when treated with 
meloxicam following a sterile inflammatory stimulus. Other studies evaluating 
meloxicam however, have not observed a concomitant decrease in PGE2 
following the induction of similar painful or inflammatory conditions, perhaps 
indicating the timing of meloxicam administration or the severity of the stimulus is 
relevant to induction of COX-2 enzyme (Fraccaro, 2013).  
Cortisol 
 Cortisol has been studied as a marker of the stress response associated 
with pain with several models including dehorning and castration. It is an indirect 
measure of the HPA axis and autonomic nervous system activation. Two studies 
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evaluating the impact of meloxicam on cortisol concentration following cautery 
dehorning demonstrated a peak in cortisol within 4 – 6 hours after the procedure. 
This time frame suggests the pain response and activation of the HPA axis is 
delayed until the effect of local analgesics had dissipated. Both groups in each 
study had the benefit of local anesthesia yet, in spite of the immediate effect on 
cortisol concentration in both groups, calves treated with meloxicam continued to 
demonstrate significantly lower cortisol responses compared to non-treated 
calves. (Allen et al., 2013; Heinrich et al., 2009). In the present study, peak 
cortisol concentration for placebo-treated control cows at 4 hours post-
operatively displayed a similar pattern, indicating a similar delay in induction of 
the stress response after return of sensation to the previously anesthetized area. 
Meloxicam treatment, however, abrogated the rise in cortisol during that time 
frame and treated cattle maintained significantly lower cortisol concentration. 
This suggests that, in addition to the pain mitigation of local anesthesia, 
meloxicam alleviated pain sufficiently to blunt the stress response in treated 
cattle.   
 CBG is the major binding protein of cortisol in the blood. In the face of 
inflammation, CBG concentrations decrease in response to an increase of 
elastase from activated neutrophils (Lewis & Elder, 2014). The degradation of 
CBG releases bound cortisol, making it available at the site of inflammation, and 
increasing free cortisol concentrations (Bladon et al., 1996). However, because 
free cortisol has a short half-life of approximately 2 minutes and is rapidly 
54 
 
metabolized, total cortisol concentrations may be unchanged or underestimated 
when CBG is low (Trevisi et al., 2013). For this reason, a higher than normal total 
cortisol can be assumed to be correct, whereas a lower cortisol may not be an 
accurate assessment of inflammation and ongoing stress.  
 In this study, CBG was not significantly different between groups but did 
increase over time after surgery. As a negative acute phase protein, CBG would 
have been expected to decrease throughout the observation period. A rising 
CBG concentration is contrary to the currently established interactions of CBG 
and the inflammatory process. In humans evaluated post-operatively or during 
sepsis, CBG characteristically decreases in response to inflammation (le Roux et 
al., 2003: Bladon et al., 1996; Ingenbleek & Young, 1994). In these reports, CBG 
measurement was made immediately post-operatively and may not accurately 
reflect ongoing changes in those patients. Relevant examples of the change in 
CBG in response to inflammation over time in cattle are limited, but Sharma et al. 
observed a static to slightly increasing CBG concentration during the clinical 
phase of anaplasmosis in cattle. (Sharma, 1986) When considered with results 
from the present study, it suggests that CBG may have different induction stimuli 
and more research into CBG alternations during inflammation and surgery are 
warranted.  
 The free cortisol index is the ratio of total cortisol to CBG. This ratio 
permits the assessment of cortisol that is biologically active in the context of 
variations in CBG and reflects free cortisol more accurately than total cortisol 
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concentrations (Dhillo et al., 2002). In the present study, FCI was did not 
significantly differ between groups. However, there was a trend toward increased 
FCI in non-treated cattle at 4 hours post-operative, paralleling a rise in total 
cortisol at the same time point. In the face of concurrent static CBG 
concentrations, this suggests a rise in free cortisol and stronger induction of the 
HPA axis in non-treated cattle compared to meloxicam treated cattle.  
 Fibrinogen was not significantly different between treatment groups, 
however there was a significant interaction between concentration and time. 
Despite an elevation for both treatment groups between 4 – 120 hours, all cattle 
remained within or below established reference ranges (300-800 mg/dL). This 
finding is consistent with other studies where Fb was not elevated in cattle 
affected with displaced abomasa and surgical correction. McSherry et al in a 
review of Fb concentrations in cattle following DA correction, animals that 
developed post-operative complications such as peritonitis where the only 
individuals with concentrations above reference ranges, while the majority of 
cattle remained normal. (McSherry et al., 1970) This suggests that the 
inflammation associated with laparotomy alone is insufficient to induce a 
profound Fb response. Additionally, a retrospective analysis of cattle presenting 
with naturally occurring dystocia or right- or left- sided DA, surgical intervention 
did not influence Fb concentration. (Hirvonen & Pyorala, 1998).  In the present 
study, with the exception of one animal whose data were discarded for analysis, 
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there was minimal sequalae associated with surgery and perhaps limited 
induction of Fb.  
 Haptoglobin is a positive APP produced in the liver. In healthy adults, Hp 
is present at less than 100 µg/mL. However, in acute inflammation, Hp 
concentration can greater than 100-fold within 48 to 96 hours (Bannikov et al., 
2011). The limitations of Hp as a diagnostic indicator include a lack of specificity 
as to the source of inflammation and extended half-life with limited discrimination 
between acute and chronic inflammation (Bannikov et al., 2011). A study by 
Mainau et al. (2014) found that the administration of meloxicam to naturally 
calving dairy cattle, not experiencing dystocia, had no effect on Hp concentration 
(Mainau et al., 2014).  The lack of effect was, in their estimation, due to an 
imprecise timing of administration in relation to the delivery process and an 
overall lack of inflammatory response in normal births. In addition, they 
concluded that cattle experiencing dystocia may still benefit from meloxicam 
treatment, despite a lack of response in normal births. In the present study, Hp 
concentrations were significantly increased at 72 and 96 hours after surgery in 
placebo-treated control cows compared to meloxicam treated cows. All animals 
were evaluated daily by blinded, experienced personnel and consistently 
displayed low clinical illness scores, suggesting elevations in Hp were solely 
induced by the experimental laparotomy and was significantly reduced by the 
administration of meloxicam.   
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 The Hp-MMP 9 complex is found specifically in activated neutrophils and 
is release during acute inflammation. Bannikov et al. (2011), evaluated the 
diagnostic specificity of Hp, MMP-9 and the Hp-MMP 9 complex in correlation 
with the severity of naturally occurring diseases. Hp concentration was increased 
in cows with both acute and chronic inflammatory conditions, while un-complexed 
MMP-9 concentration varied greatly and was not strongly correlated severity of 
inflammation or Hp concentration. The combined Hp-MMP 9 complex however, 
was elevated in acute inflammatory conditions but not in more chronic cases and 
therefore, was a more accurate predictor of timing of the response than each 
analyte independently. In the current study, the Hp-MMP 9 complex 
concentration was significantly lower at 72 hours for control cows, in contrast to 
the predicted outcome, although all cattle demonstrated a significant time effect 
at 8, 12, 24 and 48 hours. These observations indicate that the experimental 
surgical procedure did induce complex formation, but was not affected by 
meloxicam administration.  
Conclusion 
 Although NSAIDs, specifically meloxicam, are known to have analgesic 
effects in dairy cattle, there are limited options for alleviating pain in livestock 
specifically, for post-operative pain or in lactating dairy cattle. Our results 
demonstrate that administration of meloxicam at a dose of 0.5 mg/kg SQ 
abrogated relevant markers of pain and inflammation, namely cortisol, 
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haptoglobin, and PGE2, in lactating dairy cattle following soft tissue surgery 
compared to placebo-treated control animals. 
The attributes of the elective surgical model described here include 
uniformity in the induction of the pain and inflammatory stimulus and a more 
controlled temporal comparison of treatments. Collectively, these suggest that 
laparotomy with prophylactic omentopexy a promising model for the study of 
post-operative pain in cattle. Pain and inflammation are common responses to 
surgical procedures in cattle, and this model provides an avenue to investigate 
other therapeutic techniques in the future.   
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Chapter 2 
Non-Invasive Assessment of Pain Mitigation in Cattle Following 
Soft Tissue Surgery 
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Abstract 
Mitigation of pain for surgical procedures has become a topic of concern 
for the public, producers, and veterinarians. The objective of this study was to 
determine the efficacy of meloxicam for pain mitigation in adult lactating dairy 
cattle following a right-side laparotomy with omentopexy. Twenty-four dairy cattle 
(mean age: 2.51 +/- 0.54 years), between 50 and 188 days in milk (median: 117 
days +/- 43.15 days) were enrolled. Cattle were administered a 7-day acclimation 
period to the new environment and social hierarchy and assigned blocks based 
on parity, days in milk, milk yield, and pregnancy status, and randomly allocated 
to groups Meloxicam (MEL) or placebo treated control (CON). The study had two 
phases; sham (day 0-14) and surgery (day 15-28). The objective of the sham 
phase was to collect baseline behavioral and physiologic data and permit cows to 
become acclimated to human intervention during the intensive sampling periods. 
On day 0, cattle were prepared for surgery including local blocks with lidocaine. 
Injectable meloxicam (MEL) or saline placebo (CON) was administered (dose: 
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0.5 mg/kg) 5 minutes before simulated surgery (restraint for 30 minutes) and then 
returned to their home pen for data collection. On day 15, after a 14-day washout 
period, the surgical procedure was performed. Meloxicam and saline were 
administered prior to surgery to each respective group. A right flank laparotomy, 
brief abdominal exploration, and omentopexy was performed on all animals. 
Mean nociceptive threshold (MNT) was measured using an algometer and 
collected at hours 0, 1, 4, & 8 after sham and hours 0, 1, 2, 4, 8, 12, 24, 36, 48, 
60, & 72 after surgery. Infrared thermography (IRT) was taken of the incision site 
at hours 0, 1, 4, & 8 hours after sham and 0, 2, 4, 8, 12, 24, 36, 48, 60, & 72 after 
surgery. There was no difference for MNT (P=0.24) or IRT (P=0.68). This study 
indicates that meloxicam does not significantly affect these measures and that 
the use of these technologies need to be studied further for its usefulness in 
accessing pain in cattle.  
 
Introduction 
 Cattle are frequently subjected to painful procedures related to health 
interventions or production management. These may include dehorning, 
castration, or surgical correction of displaced abomasum and caesarean 
sections. Current practitioner and producer surveys indicate changing 
perspectives on the inherent benefit of pain mitigation for livestock species. This 
underscores the need for evidenced based recommendations and FDA approved 
medications. At present, there are no treatments approved for the alleviation of 
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pain due to soft tissue surgery in the US. Recently a transdermal flunixin 
meglumine product was approved for use in treating pain associated with foot rot 
in beef cattle and dairy calves, but is not approved for adult dairy cattle greater 
than 20 months of age.  
A major roadblock in evaluating the efficacy of pain management under 
experimental conditions is the prey nature of cattle. Cattle demonstrate a 
profound behavioral modification involving the masking signs of pain and distress 
in order to appear fit in the presence of danger. Therefore, accurate assessment 
of pain can be difficult and requires specialized equipment and training to detect 
subtle behavioral cues. The cattle industry needs innovative, noninvasive 
methods of detecting pain and distress in cattle. Two possible methods are mean 
nociceptive thresholds and infrared thermography.  
 Mechanical Nociceptive Threshold (MNT) is the mean threshold at which 
an animal will respond to a painful stimulus. Another interpretation is the 
maximum pain stimulus an animal will endure before altering its behavior. MNT is 
measured by pressure algometry were and observer consistently applies 
increasing force applied to specific tissues. When a pain tolerance threshold is 
breached, the stimulus induces a withdrawal or avoidance response. This 
threshold can be highly modulated based on factors within the tissue such as 
trauma as well as external factors such as physiologic and psychologic states as 
well as the use of desensitizing medications. Following a surgical disruption of 
tissue, inflammation is induced at the surgical site and is a necessary precursor 
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to healing. An exaggerated or uncontrolled inflammatory process can potentially 
create more sensitivity and pain. Therefore, MNT can provide an objective 
assessment of the nociceptive threshold and provide a useful means of 
determining the efficacy of pain therapy.  
MNT has been used primarily in the detection of lameness and monitoring 
sensitivity of hoof lesions in cattle. Laven et al described differences in MNT 
comparing corrective trimming and/or NSIAD therapy on allodynia inducing hoof 
lesions in dairy cattle (Laven et al., 2008). Raundal et al (2014) later compared 
the accuracy and precision of hand held algometers in loose-housed dairy cows 
and concluded that these devices poor reproducibility between observers, 
suggesting that future studies habituate cows prior to application (Raundal et al., 
2014) . In a follow up study, pre-habituation prior to MNT testing, such stroking in 
an attempt to remove fear of the applicator and anticipation, increased the 
reliability of the test in dairy cattle (Raundal et al., 2015). These studies indicate 
that while MNT can be useful to assess the pain threshold in cattle, attention to 
the experimental procedure and technique is necessary to produce valid 
measurements.  
 Infrared thermography is an imaging technique that detects radiation in the 
long-infrared spectrum and translates that data into a color map or thermogram. 
The amount of radiation emitted by a surface is affected by its intrinsic 
temperature. In warm-blooded animals, physiologic changes, such as 
inflammation or infection, that alter vascular resistance and increase blood flow 
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to a tissue, subsequently increase the surface temperature of the overlying 
cutaneous tissues. These changes can be monitored and provide a non-invasive 
tool for clinical assessment. In cattle, thermography has been used in the 
detection of hoof lesions (Stokes et al., 2012), to estimate tick infestation on 
cattle (Barbedo et al., 2017), in the detection of diseases(Schaefer et al., 2012) 
(Polat et al., 2010), to estimate live bull weight (Stajnko, Brus, & Hočevar, 2008), 
to determine body condition score in dairy cattle (Halachmi, Klopčič, Polak, 
Roberts, & Bewley, 2013), to measure stress in dairy cattle (Stewart et al., 2007), 
and in monitoring health and welfare of dairy cattle (Stewart, Wilson, Schaefer, 
Huddart, & Sutherland, 2017). 
 The objectives of the present study were to: 1) evaluate the efficacy of 
MNT and IRT in assessing pain and inflammation following elective right flank 
laparotomy with prophylactic omentopexy in adult lactating dairy cattle and; 2) 
use MNT and IRT to determine the efficacy of meloxicam in reducing pain and 
inflammation following soft tissue surgery in adult lactating dairy cattle.  Our 
hypothesis was that an experimental laparotomy will induce sufficient 
inflammation to reduce the MNT and increase the skin surface temperature 
adjacent to the laparotomy incision. A secondary hypothesis was that the 
administration of meloxicam will significantly reduce the pain and inflammation 
induced by the procedure such that MNT and IRT will discriminate between 
treated and non-treated control animals.  
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Material and methods 
  
The University of Tennessee Institutional Animal Care and Use Committee 
approved all experimental procedures under the supervision of the university 
veterinarian (Protocol # 2246-0314). 
The study was conducted in two phases. Animals were first subjected to a 
sham surgical procedure to ensure habituation to the intensive sampling 
procedures followed by application of the surgical procedure after a 14-day wash 
out period. Data are presented in relationship to each phase.  
 
Animals 
Twenty-four adult dairy cattle, greater than 20 months of age (mean age: 
2.51 +/- 0.54 years), were housed at the East Tennessee Research and 
Education Center - Little River Dairy Animal and Environmental Unit (Latitude: 
35.772115; Longitude: -83.850182) during the months of June, July and August 
and were maintained in an ambient temperature. Animals were between 50 and 
188 days in milk (median: 117 days +/- 43.15 days) and weighed between 512 kg 
and 705 kg (mean: 596.4 kg +/- 41.8 kg). Cows were allocated into two equal 
groups: Meloxicam (n = 12; MEL) and Control (n = 12; CON). Groups were 
balanced based on days in milk (Median: 111 days MEL; 127 days CON; Range: 
50 – 188 days), milk yield (Mean: 74.0 lbs. MEL; 77.5 lbs. CON; Range: 57.6 – 
93.1 lbs.), and pregnancy status (n = 2 MEL; n = 2 CON). Exclusion criteria for 
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enrollment in the study included clinical signs associated with potentially 
systemic inflammation (i.e. mastitis, metritis, ketosis, lameness, etc.) or history or 
evidence of previous abdominal surgery. All animals were considered healthy 
based on a physical exam performed by a veterinarian 1 day prior to the start of 
the study.  
Cattle were housed in a free stall barn approximately 20 m x 12.5 m (800 
sq. m) with 24 sand-bedded stalls and 32 headlock stanchions. Stocking density 
was maintained at 75% and did not exceed 100% during the study (lowest was 
22 cows per 24 stalls = 91%). Cattle were milked twice daily (at approximately 
7:30 AM and 4:30 PM). Milk was discarded throughout the entire of the 
experiment.  A total mixed ration (TMR) was fed ad libitum during the study and 
was formulated according to Nutrient Research Council requirements to meet or 
exceed nutrient requirements of lactating dairy cattle. Nutrient analysis of TMR 
was conducted prior to and upon completion of the study. Fresh TMR was 
prepared and dispensed twice daily in parallel with milking. Twice daily at 
approximately 12:00 PM and 6:00 PM residual TMR was pushed up the 
headlocks. Waste TMR was collected twice daily immediately prior to the 
dispensing of each new feeding and weighed to determine pen level feed intake. 
Throughout the study animals were also provided ad libitum access to water. The 
cattle were permitted 7 days prior to the initiation of the study to acclimate to the 
new environment and social hierarchy. During this time, the cattle were also 
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acclimated to handling via halters and grooming to simulate the contact 
associated with the intense sampling periods.  
Phase 1: Sham Procedure 
In order to determine the effect of the intense sampling scheme and 
experimental assessments alone without the influence of the surgical procedure, 
a sham experimental phase was imposed on the cattle. On day -1, a 14-gauge X 
13 cm polyurethane IV jugular catheter (MILACATH-Extended Use, Mila 
International, Inc. Florence, KY) was placed and were maintained with 
heparinized saline until 4 days after the procedure, at which point they were 
removed and subsequent samples taken via direct venipuncture.  
On day 0, a sham procedure was performed.  Cows were prepared for 
sham surgery by clipping and sterilely preparing. Cows were blocked with 2% 
lidocaine (90 ml or 1800 mg, local tissue infusion, VetOne, MWI Animal Health, 
Boise, ID) in a line block pattern on their right side approximately 15 cm below 
the transverse process of the 3rd lumbar vertebrae and 10 cm caudal to the 
costal arch. Meloxicam (0.5 mg/kg, Metacam®20, Boehringer Ingelheim Ltd., 
Burlington, Ontario, Canada) was administered SQ in the neck to the meloxicam 
treatment group (MEL) and saline (0.025 mL/kg, 0.9% Sodium Chloride Injection 
USP, Hospira, Inc. Lake Forest, IL) was administered SQ in the neck to the 
control group (CON). Ampicillin trihydrate (10 mg/kg, Polyflex®, Boehringer 
Ingelheim Ltd., St. Joseph, MO) was administered intramuscularly to all cows on 
the contralateral side of the neck from the treatment.  
68 
 
Four veterinarians were designated as surgeons during the study (MC, 
DA, BW, and LS). Six replicates of sham procedures occurred with 4 animals per 
cohort. Each cohort was equally balanced for MEL and CON cattle (2 MEL and 2 
CON). Each surgeon performed six procedures with equal numbers of MEL and 
CON cattle (3 MEL and 3 CON). A sham surgical simulation was performed with 
the surgeon standing adjacent to the animal while it was restrained for 30 
minutes. Procedure initiation for each cohort was staggered and administration of 
treatment and sampling time points were relative to each animal’s sham 
procedure start time.  
Following the sham procedure, cattle were returned to their home pen for 
sample collection lasting up to 7 days. Following completion of phase 1, the 
cattle were provided a 7-day washout period. Therefore, a total of 14 days 
following administration of the meloxicam or saline placebo elapsed prior to 
initiation of phase 2.    
Phase 2: Surgical Procedure 
The methods used for the phase 2 were similar to those executed during 
phase 1 with the exception of preforming right flank laparotomies with 
prophylactic omentopexy for all cattle. Briefly, on day -1 before the surgical 
procedure, cattle were refitted with heart rate monitors and jugular catheter was 
placed. As previously, jugular catheters were maintained with heparinized saline 
through the first 96 hours of the sampling period then removed and subsequent 
blood samples collected via direct venipuncture. On day 0, approximately 5 
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minutes prior to the initiation of each animals’ surgical procedure, meloxicam (0.5 
mg/kg) was administered SQ in the neck to the meloxicam treatment group 
(MEL) while a saline placebo (0.025 mL/kg) was administered SQ in the neck to 
the control group (CON). Ampicillin trihydrate (10 mg/kg) was administered 
intramuscularly to all cows on the contralateral side of the neck from the 
meloxicam or saline treatment. 
The same four veterinarians carried out the surgical procedures in 6 
replicates of 4 cows. All treatments were balanced within each cohort and 
balanced across each surgeon. Each laparotomy, abdominal exploratory and 
prophylactic omentopexy were performed according to a standardized protocol. 
The right paralumbar fossa was clipped, the skin was aseptically prepared, and a 
line block with lidocaine (120mL of lidocaine) was performed as previously 
described. After aseptic preparation, a 15 cm vertical incision was made starting 
10-cm caudal to the caudal curvature of the last rib and 15 cm ventral to the 
transverse process of the 3rd lumbar vertebrae. The incision progressed through 
the skin, external abdominal oblique muscle, internal abdominal oblique muscle, 
transversus abdominus muscle, and peritoneum. The surgeon then placed the 
left arm into the abdomen and briefly explored the abdomen to identify and 
palpate the rumen, omentum and abomasum. Similar to the techniques 
described in Turner and McIlwraith’s Techniques in Large Animal Surgery (2013), 
a standard omentopexy was performed by suturing the omentum, peritoneum 
and transversus closed using #2 polyglactin 910 (Vicryl, Ethicon, Inc. Somerville, 
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NJ) in a simple continuous pattern. The external abdominal oblique muscle and 
internal abdominal oblique muscle were also closed using #2 polyglactin 910 in a 
simple continuous pattern. Finally, the skin was closed using #4 nylon (Supramid 
Extra II. S. Jackson, Inc. Alexandra, VA) in a continuous interlocking pattern. 
MNT 
Mechanical nociceptive threshold was measured using a pressure 
algometer (Wagner Mark-10 M3, Wagner Instruments, Greenwich, CT) using a 
conical steel tip (FD/S-3, Wagner Instruments, Greenwich, CT, Figure 19). 
During the sham phase, MNT was measured at hours 0, 1, 4, and 8 respective to 
time 0 hours beginning immediately prior to the sham procedure and during the 
surgical phase at hours 0, 1, 2, 4, 8, 12, 24, 36, 48, 60, and 72 hours respective 
to time 0 hr. prior to the surgical procedure. For each time point and for both 
phases, the right flank adjacent to the mock or actual incision was divided into 6 
test locations (Figure 20). Cows were randomly assigned to one of two starting 
positions where measurements were initiated. These were either the cranial 
group, where the sequence of measurements proceeded as 1, 2, 3, 4, 5, 6 or the 
caudal group where the sequence proceeded 4, 5, 6, 1, 2, 3. The assignment 
and sequence remained constant for each cow and all MNT measurements and 
were balanced across treatment groups. Immediately prior to measurement, the 
cattle were restrained using a halter or headlocks within the pen. The observer 
placed a hand gently on the incision to habituate the cow to their presence before 
the measurement was taken. The algometer was applied at a steady force of 
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approximately 1 kgf/s to each of location until the cow presented an avoidance 
response. These responses included movement away from the pressure, tail 
flicking, ear twitching, looking back and kicking. All MNT measurements were 
carried out by the same individual who was blinded to treatment.  
IRT 
Thermograms were obtained of each cow at hours 0, 1, 4, and 8 hours 
beginning immediately prior to the sham procedure and at hours 0, 1, 2, 4, 8, 12, 
24, 36, 48, 60, and 72 hours beginning immediately prior to the surgical 
procedure. Cows were restrained using a halter or headlocks located within the 
pen. The camera (Med2000TM, Meditherm, Inc. Fort Myers, FL) was positioned 
approximately one-meter distance from the incision so that the entire incision and 
paralumbar fossa was included in the image. Triplicate images were taken for 
each time point and saved for future analysis. Using the accompanying software 
(IRIS 7.5, WinTes II, Meditherm, Inc. Fort Myers, FL), the incision was isolated 
from the image using the programs cropping function, and the maximum, 
average, and minimum temperatures were recorded for each thermogram.  
Statistical analysis  
All statistical analyses were performed in Statistical Analyses System 
(SAS Version 9.1: SAS Institute Inc., Cary NC; 1991-2001). The level of 
significance was established to be P< 0.05.  
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 Normality test of the data and residuals was performed for each indicator. 
MNT was normally distributed following log transformation then was analyzed 
using the GLIMMIX procedure. All sites were averaged to give one reading per 
time period to get the average reading. During the analysis, hours 0 and 1 were 
removed from the time by treatment interaction. Animal ID and cranial site vs 
caudal sites were used as a random effect. Surgeon and surgery block were 
analyzed as random effect but had no significant effect and were removed from 
the model. Fixed effects included treatment group. Time was used as a repeated 
measure. Next, the three cranial sites and three caudal sites were divided, 
averaged and analyzed. Tukey adjustment was used for MNT.  
Maximum, mean and minimum temperatures for IRT were normally 
distributed. Fixed effects included treatment group. Time was the repeated 
measure.  Animal ID was used as a random effect. Protected LSD was used for 
adjustment. Surgeon and time of surgery (surgery block) was analyzed as a 
random effect, but did not have a significant effect on any blood markers and was 
therefore removed from the analysis.  
Results 
 Two cows were removed from the study and not included in the results. 
Cows included in the results is n = 22.   
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Mechanical Nociceptive Threshold  
All cattle demonstrated a time effect with a significantly higher tolerance of 
pressure observed at 0 and 1 hr. following the surgical procedure (P < 0.001, 
Figure 21). When the 0 and 1 hr. time points were excluded from the analysis in 
an attempt to isolate responses that occurred without the influence of lidocaine, 
the significance observed over time was removed (P = 0.24, Figure 22).  
Numerically, cattle treated with meloxicam to demonstrate a higher tolerance of 
pressure at 24- and 36-hours following surgery, but this effect was not significant 
(P = 0.37). Location with respect to the incision on the MNT demonstrated a 
significant difference, with the cranial sites requiring less force to elicit a 
response (lower MNT) than the caudal sites (P = 0.03, Figure 23Figure ). 
However, randomization of the start site had no effect on the overall MNT and 
therefore was not included as a variable in the model.  
Infrared Thermography 
A significant time effect was observed for the maximum, average, and 
minimum IRT observations for all animals (P< 0.001 for each corresponding 
variable, Figure 24). There were no significant differences observed between 
treatments or time by treatment interaction of the maximum skin surface 
temperatures (P = 0.46 and 0.71 respectively, Figure 25). Cattle administered 
meloxicam had slightly lower average and minimum surface temperatures at 2 
hours following the surgery, but an overall treatment and time by treatment effect 
was not observed (P = 0.91 and 0.67; P = 0.42 and 0.63, respectively, Figure 26 
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and Figure 27). Table 1 displays the values for maximum, mean, and minimum 
temperatures.  
Discussion 
 In the present study, pressure algometry and IRT were used to evaluate 
pain sensitivity and inflammation following an elective right flank laparotomy with 
prophylactic omentopexy. Each technology successfully detected changes over 
time compared to baseline observations. The administration of meloxicam 
however, did not alter pain sensitivity or skin surface temperature sufficiently to 
discriminate between treated and non-treated cattle.  
In our study, the meloxicam treated cattle had significantly higher MNT 
recordings than control cattle at baseline and 1-hour post-operative. This could 
be the result of type 1 error, despite efforts to randomize cattle to groups. The 
baseline measurements were taken prior to the administration meloxicam and 
lidocaine and based on the reported pharmacokinetics of meloxicam, it’s doubtful 
therapeutics concentrations were present at 1-hour post-administration. When 
these time points were removed from the analysis, no significance was found at 
all other clinically relevant time points. However, the time effect for all animals 
does demonstrate that the surgical model created surgical and inflammatory pain 
that was quantifiable using algometry.  
Another finding in the present study was the differences observed 
between sites cranial and caudal to the incision. We believe this is due to the 
severing of the superficial innervation and loss of sensory input in the caudal 
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area as the incision was made. Although innervation was not completely 
removed as evidence by reduced MNT for all caudal measurements compared to 
baseline, the fact that some sensation was removed is interesting and selection 
of response sites should be considered carefully for future studies.  
Several studies have evaluated MNT changes in cattle following 
dehorning.(Allen et al., 2013; Heinrich et al., 2010; Stock et al., 2016; Tapper et 
al., 2011) A common experimental design of these studies has been to collect 
baseline observations prior to induction of the painful procedure, as has been 
done here. In each of these studies, a significant reduction in MNT was observed 
from baseline samples prior to dehorning compared to post-dehorning 
observations. Another frequent design aspect is to maintain an independent 
cohort that receives a sham procedure concurrently with animals receiving the 
actual procedure. In the study presented here, the sham procedure was 
conducted on the principal animals 2 weeks prior to initiation of the surgical 
procedure. The advantages of this approach are the habituation of the animal to 
sample collection and the direct comparison of results within the same animal. 
Both approaches provide consistent application of the methodology and 
comparison between affected and non-affected groups.  
It appears that pressure algometry and MNT are most useful in the 
presence of inflammation and active lesions. This bears true when the technique 
has been applied to naturally occurring and experimentally induced lameness. 
Whay et al. (1997) found a significant correlation between the severity of visually 
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assessed lameness scores and pressure sensitivity in primiparous Holstein 
heifers (Whay et al., 1997). Cutler et al (2013) demonstrated that digital 
dermatitis lesions could be accurately identified by MNT as active, healing, or 
healed lesions (Cutler et al., 2013).  Likewise, Mohling et al. (2014) observed a 
reduction of as much as 50% MNT in sows being subjected to chemically 
induced lameness (Mohling et al., 2014). On the other hand, Wheeler et al (2013) 
found that the probability of healthy calves to respond to pressure externally 
applied to joints did not correlate with other indicators of inflammation and 
therefore pressure algometry was not recommended for the assessment of 
lameness in young calves (Wheeler et al., 2013).   
Millman (2013) discusses the need to refine this technique by providing 
proper restraint and blind folding calves to avoid anticipation and fear-based 
responses. This would lead to more reliable testing for both intraobserver and 
interobserver measurements. Raundal et al. found a high level of individual 
animal variation and low agreement of MNT readings between observers 
(Raundal et al., 2014). Tallant et al., found dogs became accustomed to 
algometry and tolerance varied by position and observer (Tallant et al., 2016). 
Blindfolding was not performed in the current study and the only attempt to 
acclimate and normalize responses was the placement of the observer’s hand 
near the incision. Perhaps had additional efforts been used to remove the 
anticipatory effects of the approaching observer, greater differences among the 
treatment groups would have been observed.  
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 Changes in the maximum, mean and minimum skin surface temperatures 
at the surgical site were observed over time for both treatments, suggesting the 
successful induction of physiologic mechanisms that influence these 
temperatures. Maximum and mean temperatures increased from baseline and 
remained elevated throughout, while the minimum temperatures decreased from 
the time of surgery. This was likely the result of post-operative inflammation and 
was an expected response as has been described with IRT mapping of surgical 
wounds (Celeste et al., 2013).  
The administration of meloxicam did not appear to alter the inflammatory 
process at the level of the incision sufficiently to induce detectable differences in 
skin temperature. However, there was a numerical trend for treated cows to have 
lower mean and minimum skin temperatures at 2 hours. In most recent studies, 
utilizing IRT in cattle, the technique is more often used to monitor periocular 
temperature and systemic autonomic responses to painful conditions (Coetzee et 
al., 2012; Schaefer et al., 2012; Stewart et al., 2009; Stewart et al., 2010). In 
many of these studies, NSAID therapy has reduced periocular temperature and 
stabilized the autonomic or stress induced response. In the current study, 
periorbital temperature was not recorded and the impact of the changes in the 
autonomic nervous system on skin temperatures at the surgical site is unknown, 
but presumably has limited effect.  
 An unexpected observation made during the analysis of the thermograms 
revealed a spurious assignment of low temperatures associated with the suture 
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material in each incision. Each surgeon left an irregular length of suture tag, 
where longer tags had an influence on the range and minimum surface 
temperatures assigned in the region of interest, which could not be excluded. 
However, these variations as well as other animal independent differences were 
accounted for in the statistical model during final analysis.  
 To our knowledge, this is the first study to evaluate the efficacy of 
meloxicam as post-operative pain management for cattle following a simulated 
surgical DA repair. Barrier et al. (2014) evaluated beef cattle undergoing 
cesarean section and found that meloxicam treated cattle had greater lying times 
in the first 16 hours after delivery. An additional head to head to clinical trial 
comparing meloxicam and ketoprofen in cattle after rumen fistulation surgery, 
found evidence of pain after surgery, but no differences between treatments. 
These studies suggest a limited efficacy of meloxicam in soft tissue surgery, but 
this appears to be in stark contrast to studies evaluating its efficacy in other 
painful conditions. For example, multiple studies have revealed a benefit from 
meloxicam treatment in reducing stress and inflammatory biomarkers, improving 
pressure tolerance and MNT, and improving behavioral responses of cattle 
undergoing cautery dehorning, castration, mastitis and transportation. Therefore, 
care should be used when drawing the conclusion that meloxicam therapy is 
ineffective for pain mitigation associated soft tissue surgery.   
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Conclusions 
 Although a difference between treatment groups was not detected, MNT 
and IRT are promising noninvasive technologies for inflammatory pain detection. 
These technologies would be ideal for monitoring pain sensitivity and 
inflammation following surgical interventions and would be useful in assisting 
veterinarians and producers in making decision about pain management.  
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Conclusions 
 
 
Approximately 470,000 cows undergoing painful surgical procedures 
every year, producers and veterinarians are seeing the effects of pain first hand. 
Objective measurements are need to quantify this pain as well as a model to 
research this pain and analgesic methods.  
This study presents several possible methods of measuring pain including 
blood parameters and non-invasive objective technology. The blood biomarkers 
that demonstrated the highest degree of difference in meloxicam treated cattle 
compared to placebo-treated control cattle were PGE2, haptoglobin, and cortisol. 
Cows that received meloxicam had significantly lower PGE2 levels at 2 and 8 
hours after surgery (P= 0.0044 and P=0.0001, respectively), significantly lower 
haptoglobin levels are 72 and 96 hours after surgery (P = 0.0153 and 0.0002, 
respectively), and significantly lower cortisol levels at 4 hours after surgery (P < 
0.0001) than placebo-treated controls. Although fibrinogen showed no significant 
difference between the groups, fibrinogen concentration did show a time effect (P 
< 0.0001), though these changes never increased over a clinically relevant 
threshold.  
 This study also evaluated mechanical nociceptive threshold and infrared 
thermography. MNT measurements in cattle treated with meloxicam trended to 
demonstrate a higher tolerance of pressure at 24- and 36-hours following 
surgery, but this effect was not significant (P = 0.3710). Cattle administered 
meloxicam had slightly lower mean and minimum skin surface temperatures at 2 
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hours following the surgery, but an overall treatment and time by treatment effect 
was not observed (P = 0.9144 and 0.6736; P = 0.4186 and 0.6277, respectively). 
While these non-invasive methods did not detect a difference between the 
treatment groups, it did detect a change in the post-operative period, confirming 
that this surgical model does in fact create inflammation and pain that is 
quantifiable. These observations are consistent with the routine inclusion of these 
technologies in other pain studies and underscores the relevance of their use in 
pain studies in cattle.  
This study demonstrates meloxicam provides analgesia for dairy cattle 
undergoing soft tissue surgery. Moreover, this study demonstrates that cattle 
experience pain and should be provided multi-modal analgesia for painful 
procedures. As responsible advocates of agriculture and animal welfare, it is the 
animal agriculture community’s duty to see that these animals are treated 
appropriately. We should be at the forefront of these issue and determining the 
best way to provide the best well-being to these animals based on sound 
scientific research.  
More research is needed to advance pain management for cattle. 
Because these animals are stoic and difficult to assess pain in, new and 
innovative methods of detecting pain are needed. This study has found methods, 
both blood parameters and technologies, that address this issue. More of these 
techniques are needed to further improve our ability to assess pain. It also 
demonstrates using a unique surgical model to create and then assess pain in 
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dairy cattle.  Finally, from this study, not only have we provided a number of 
assessment tools of pain, but have also confirmed the use of meloxicam as an 
analgesia. There is a major need for research to prove that not only meloxicam, 
but other analgesic methods are not only useful tools but warranted measures 
both as a single modality or in a multi-modal approach.  
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Figure 1 – Sham PGE2 concentrations by treatment group  
PGE2 concentration for control cattle (shaded) and meloxicam treated cattle 
(solid) were significantly different between the treatment groups during the sham 
prodecure (P = 0.02). 
 
 
Figure 2 – Sham PGE2 concentrations over time in all cattle  
PGE2 concentrations were determined at each time point for all cattle over time 
during the sham phase. Data represent the mean for all cattle over time. PGE 
was affected by time (P < 0.001). 
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Figure 3 – Surgical PGE2 concentrations in 
meloxicam and placebo-treated cattle   
Least square means PGE2 concentrations in 
placebo-treated cows (dash line and □) and 
meloxicam-treated cows (solid line and ●) over 
time after an elective laparotomy with 
prophylactic omentopexy. A time by treatment 
interaction was observed (P = 0.003). Control 
cows had significantly higher PGE2 levels at 2 
and 8 hours after surgery than meloxicam 
cows (P = 0.004 and P < 0.001, respectively). 
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Figure 4 – Sham total cortisol over time for all cattle 
Total cortisol concentrations were determined at each time point during the sham 
procedure. Data represent the LS mean for all cattle over time. There was a 
significant difference over time (P = 0.015) 
 
 
Figure 5 – Sham CBG concentration over time for all cattle  
CBG concentration was determined at each time point during the sham 
procedure. Data represent the LS mean for all cattle over time. There was a 
significant difference in time points (P > 0.001).  
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Figure 6 – Surgical cortisol concentration 
in meloxicam and placebo treated cattle  
LS means of cortisol (ng/mL) in placebo-
treated cows (dash line and □) and 
meloxicam-treated cows (solid line and ●) 
over time after an elective laparotomy with 
prophylactic omentopexy. Control cows had 
significantly higher cortisol concentrations 
than meloxicam cows at 4 hours after 
surgery (P < 0.001).  
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Figure 7 –Surgical Cortisol Binding 
Globulin concentration in all cattle over 
time 
LS means of CBG for all animals over time 
following elective laparotomy with prophylactic 
omentopexy. CBG was affected by time (P > 
0.0001) but not by treatment group or time by 
treatment interaction (P = 0.1396 and P = 
0.5187, respectively). 
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Figure 8 – Surgical Cortisol Binding 
Globulin (CBG) in meloxicam and placebo 
treated cattle  
LS means of CBG (mg/L) in placebo-treated 
cows (dash line and □) and meloxicam-
treated cows (solid line and ●) over time 
after an elective laparotomy with prophylactic 
omentopexy. CBG was affected by time, but 
there was not difference observed between 
treatment or time by treatment interaction (P 
= 0.14 and P = 0.52, respectively) 
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Figure 9 – Free cortisol index (FCI) for all cattle 
following elective laparotomy  
LS means of FCI over time after elective laparotomy with 
prophylactic omentopexy. FCI was affected by time (P < 
0.001), but not by treatment or time by treatment 
interaction (P = 0.34 and P = 0.29, respectively). 
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Figure 10 – Free Cortisol Index in meloxicam and placebo-
treated cattle over time  
LS means of FCI (nmol/mg) in placebo-treated cows (dash line 
and □) and meloxicam-treated cows (solid line and ●) over time 
after an elective laparotomy with prophylactic omentopexy. FCI 
was affected by time, but there was not difference observed 
between treatment or time by treatment interaction (P = 0.34 and 
P = 0.29, respectively) 
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Figure 11 – Sham Fibrinogen concentration in all cattle over time  
Fibrinogen concentration (mg/dL) in all cattle over time for all cattle showed a 
significant time effect (P > 0.001) but did not show a treatment (P = 0.52) or time 
by treatment interaction (P = 0.96). 
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Figure 12 – Surgical Fibrinogen 
concentration in all cattle over time 
LS means of fibrinogen for all animals over time 
after elective laparotomy with prophylactic 
omentopexy. A time effect was seen in response 
to the time of surgery (P < 0.001). 
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Figure 13 – Surgical Fibrinogen 
concentrations in meloxicam and placebo-
treated cattle  
LS means fibrinogen concentration in placebo-
treated cows (dash line and □) and meloxicam-
treated cows (solid line and ●) over time after an 
elective laparotomy with prophylactic 
omentopexy. Treatment groups did not differ (P 
= 0.56) nor was a time by treatment interaction 
observed (P = 0.43).  
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Figure 14 – Sham Haptoglobin concentrations over time for all cattle  
Haptoglobin concentration slowly increased after the first 24 hours during the 
sham procedure over time for all cows (P = 0.0019). 
 
 
Figure 15 – Sham Haptoglobin and Matrix Metalloproteinase 9 complex 
concentration in all cattle over time  
Hp and MMP 9 complexes displayed spikes at 24 hr. and 120 hr. after sham 
procedure with an overall a significant time effect (P > 0.0001). 
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Figure 16 – Surgical Haptoglobin 
concentration in meloxicam and placebo-
treated cattle 
LS means haptoglobin concentration in placebo-
treated cows (dash line and □) and meloxicam-
treated cows (solid line and ●) over time after an 
elective laparotomy with prophylactic 
omentopexy. CON had significantly higher Hp 
concentrations (mcg/mL) at 72 and 96 hours 
after surgery (P = 0.0153 and 0.0002, 
respectively). 
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Figure 17– Surgical Haptoglobin and Matrix 
Metalloproteinase 9 complex concentration in meloxicam 
and placebo-treated cattle 
LS means of Hp-MMP 9 complex concentration in placebo-
treated cows (dash line and □) and meloxicam-treated cows 
(solid line and ●) over time after an elective laparotomy with 
prophylactic omentopexy.  A time effect and a time by treatment 
interaction was found (P < 0.0001 and P = 0.0107, respectively) 
but no treatment effect was observed (P = 0.5317). Contol cows 
had a significantly lower Hp-MMP 9 complex concentration at 72 
hours post surgery.   
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Figure 18 – Surgical Matrix Metalloproteinase concentration in all 
cattle over time 
LS means of Hp-MMP 9 complex concentrations in all cows over time 
after elective laparotomy with prophylactic omentopexy. A significant 
time effect was observed (P < 0.0001). Hours 8, 12, 24, and 48 were 
significantly higher in all cows after surgery. 
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Figure 19 - FD/S-3 conical 
steel tip used for MNT 
measurements. 
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Figure 100 - Example of algometry sites 
around the incision. Sites 1, 2, and 3 are 
cranial sites and 4, 5, and 6 are caudal sites.  
118 
 
 
0
1
2
3
4
5
6
7
8
0 1 2 3 8 12 24 36 48 60 72
M
N
T 
(f
o
rc
e
)
Hours After Surgery
MNT over Time
Figure 21 – Mechanical nociceptive threshold following a right 
flank laparotomy and prophylactic omentopexy (including 
times 0 and 1 hour) 
There was a significant time effect observed with hours 0 and 1 
being significantly higher than all other hours (P < 0.001). Prior to 
the surgical procedure, lidocaine was used to induce local 
anesthesia. The significant decrease in the pain threshold at hour 2 
demonstrates the change in sensitivity to pressure due to 
inflammation and surgical pain without the influence of lidocaine.  
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Figure 22 - Mechanical nociceptive threshold following a right 
flank laparotomy and prophylactic omentopexy in cattle treated 
with meloxicam or placebo (excluding times 0 and 1 hour) 
There was no significant difference between treatment groups 
(MEL; solid line with circles, CON; dashed line with open squares, P 
= 0.37). No time by treatment interaction was observed (P = 0.24) 
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Figure 23 - Combined mean MNT for all cranial and caudal test sites 
for all cattle 
There was a significant difference between the cranial and caudal 
readings across all cows with the cranial sites requiring less force to elicit 
a response (lower MNT) than the caudal sites (P = 0.031). 
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Figure 24 – Maximum, Mean, and Minimum skin surface temperatures 
collected by infrared thermography on all animals over time  
Maximum (dashed with squares), mean (solid with circles), and minimum 
(dotted with diamonds) temperatures displayed a significant time effect 
(P<0.001, for each variable).  
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Figure 25 - Maximum skin surface temperatures collected by infrared 
thermography following a right flank laparotomy and prophylactic 
omentopexy in cattle treated with meloxicam or placebo.  
The least square mean of the maximum IRT temperatures were affected by 
time (P< 0.0001), but showed no significant difference between treatment 
and time by treatment interaction (P = 0.46 and 0.71 respectively). 
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Figure 26 - Mean skin surface temperatures collected by infrared 
thermography following a right flank laparotomy and prophylactic 
omentopexy in cattle treated with meloxicam or placebo.  
The least square mean of the mean surface temperatures was affected by time 
(P < 0.001), but showed no significant difference between treatment and time 
by treatment interaction (P = 0.91 and 0.67 respectively). 
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Figure 27 - Minimum skin surface temperatures collected by infrared 
thermography following a right flank laparotomy and prophylactic 
omentopexy in cattle treated with meloxicam or placebo.  
The least square mean of the minimum IRT temperatures were affected by 
time (P < 0.0001), but showed no significant difference between treatment 
and time by treatment interaction (P = 0.42 and 0.63 respectively). 
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Table 1 – Maximum, Mean and Minimum skin surface temperature within 72 hours of elective right flank 
laparotomy with prophylactic omentopexy 
a-d represent significant differences between LS means of temperature within columns over time for all cows 
 
 
 
 
 
 
 
 
 
 
 
 Maximum Temperatures Average Temperatures Minimum Temperatures 
Hours 
After 
Surgery 
LS Mean of 
Temperature 
Standard 
Error 
LS Mean of 
Temperature 
Standard 
Error 
LS Mean of 
Temperature 
Standard 
Error 
0 32.3619 a 0.3037 33.7420 d 0.1928 32.3619 a 0.3037 
2 31.3499 cd 0.3037 34.9772 bc 0.1928 31.3499 cd 0.3037 
4 31.2245 d 0.3037 34.7308 c 0.1928 31.2245 d 0.3037 
8 31.5420 bcd 0.3037 34.9952 bc 0.1928 31.5420 bcd 0.3037 
12 31.1350 d 0.3037 34.8856 c 0.1928 31.1350 d 0.3037 
24 31.2822 d 0.3037 34.8861 c 0.1928 31.2822 d 0.3037 
36 32.1091 abc 0.3111 35.5564 a 0.1974 32.1091 abc 0.3111 
48 32.2800 ab 0.3037 35.4355 ab 0.1928 32.2800 ab 0.3037 
60 31.1001 d 0.3037 34.8668 c 0.1928 31.1001 d 0.3037 
72 31.5238 abcd 0.3331 34.9008 bc 0.2113 31.5238 abcd 0.3331 
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